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Abstract
Lung development is a complex process orchestrated by as many as 40 dierent
types of cells and many signaling and regulatory factors. The spatial sequence of
branching of bronchial epithelial tubes is known to be stereotyped. However, it
remains unknown how the timing of branch formation is encoded and whether this
branching clock function is unique for dierent tissue types or is conserved across
species and lineages that undergo iterative branching. Investigations of the function
of the sarcoplasmic-endoplasmic reticulum calcium ATP-ase (SERCA) reveal that
protein kinase C (PKC)-modulated SERCA activity controls branch formation across
tissues and species.
SERCA pumps calcium from the cytoplasm into the endoplasmic reticulum (ER),
where it is stored for release back into the cytoplasm by the binding of inositol
trisphosphate (IP3) to the IP3 receptor in the ER. PKC modulates the amount of
IP3 present, and the balance between PKC and SERCA activity establishes various
patterns of calcium dynamics in the cell.
SERCA controls intersomitic blood vessel sprouting and branching in zebrash
embryos. The rate of outgrowth of vessels is controlled by SERCA activity in a dose-
dependent manner as revealed by graded inhibition of the pump. Vessel sprouting
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recovers upon removal of inhibition and restoration of pump activity. SERCA controls
the rate of vessel growth and budding by regulating endothelial cell motility.
During Drosophila embryonic development, SERCA activity is required for the
proper formation of the network of tracheal tubules that deliver oxygen to tissues
during larval stages of development. In the embryo, this system forms entirely by
migration of epithelial cells following cessation of cell proliferation. SERCA blockade
results in breaks in the tracheal structure. Removal of inhibitor partially rescues the
defects, while simultaneous treatment with both SERCA inhibitor and PKC activator
remarkably rescues tracheal structure. Thus, SERCA governs branch formation in
a system that is entirely independent of cell proliferation, and PKC activation can
largely compensate for SERCA inhibition.
Similarly, SERCA activity is necessary for Drosophila embryonic central nervous
system development as revealed by the formation of the longitudinal axon fascicles.
Disruption of SERCA activity generates breaks, displaced axons, and abnormal merg-
ings of the axon tracts which are consistent with perturbed cell migration and guid-
ance. The proper neural structure is partially restored by removal of inhibition, and
the defects are again rescued by ectopic PKC activation alongside SERCA blockade.
Dynamic imaging of Drosophila embryonic tracheal morphogenesis demonstrates
that SERCA's principal function is to govern cell migration. The breaks in the
tracheal network that are observed following SERCA inhibition result from failed
migration of tracheal cells to their destined locations within the embryo.
Together, these nding reveal that SERCA regulates cell migration, and this serves
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as a conserved mechanism that governs branch formation in various cell types and
species during development. A general mechanism directing cell migration simplies
the control of branch formation and obviates the need for individual morphogenes to
specify formation of each branch of an iteratively branching tissue.
On the other hand, morphogens are important for specifying lung fate and coordi-
nating the various cell types and behaviors necessary to grow and mature a complex,
specialized organ such as the lung. Signaling between the bronchial epithelium,
mesenchyme, endothelium, the basement membrane matrix, and other players directs
the growth of the ramied structure that must form before the lung can become
functional. Nerves are also known to be present from the early stages of lung
branching. Yet a role for nerves in modulating epithelial branching remains to be
discerned. Denervation of embryonic mouse lung explants reveals that lung branching
requires nerves. Targeted neural ablation, but not inhibition of acetylcholine recep-
tors, halts lung branching and causes a reduction in endothelial cells and epithelial
and mesenchymal proliferation. Likewise, ablation of nerves in Drosophila embryos
derails tracheal morphogenesis. Therefore, nerves play a conserved role in enabling
epithelial airway branching.
These studies expand our understanding of the basic elements regulating the
development of complex branched organs, such as the mammalian lung, zebrash
vasculature, and Drosophila tracheal and neural networks. Harnessing this knowledge
may open the door to new interventions in congenital disorders or tumor angiogenesis.
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1Part I
PKC-modulated SERCA governs
branching morphogenesis by
regulating cell migration
2Chapter 1
Introduction
1.1 Lung branching is stereotyped
The lung originates as a bud from the foregut endoderm and forms by periodic,
iterative branching. The branching programs of mammalian lung and Drosophila
tracheal development are known to be highly stereotyped (Metzger et al., 2008).
Three patterns of bud elaboration give rise to the three-dimensional structure of
the lung. These are: (1) domain branching, where buds form sequentially o a
pre-existing tubule; (2) planar bifurcation, where a tip bifurcates into two; and (3)
orthogonal bifurcation, which is planar bifurcation but with a 90 degree rotation
between bifurcation events. The sequence of these budding events is nearly identical
from one individual to the next. While the spatial patterning of the lung is thus
understood, what serves as the clock that regulates the timing of branch formation
remains unknown.
31.2 SERCA in periodic muscle contraction
Conversely, cardiac muscle contractility is known to be regulated by calcium dynam-
ics. The highly periodic contractions of the heart depend on cycles of calcium inux
into the cell cytoplasm to drive muscle contraction followed by rapid sequestration
of calcium in the sarcoplasmic reticulum to repolarize the cell for a subsequent
contraction. These cycles of calcium release and calcium clearance depend on a core
group of proteins that modulate calcium dynamics (see Figure 1.1). Phospholipase C
cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) in the membrane to release
diacyl glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (Berridge, 1993). IP3
binds an IP3 receptor (IP3R) in the membrane of the endoplasmic reticulum, and this
induces release of calcium from its store in the endoplasmic reticulum (or sarcoplasmic
reticulum in muscle) (Jacob, 1990). Calcium is pumped from the cytoplasm back
into the endoplasmic reticulum by the sarcoplasmic-endoplasmic reticulum calcium
ATPase, or SERCA (Berridge et al., 2003).
This enables iterative cycles of calcium release and permits such behaviors as
muscle relaxation (Berridge and Galione, 1988). SERCA binds two calcium molecules
at a time and hydrolyzes ATP to pump calcium into the endoplasmic reticulum
against a concentration gradient to remove calcium from the cytosol in preparation
for the next release of calcium (East , 2000; Misquitta et al., 1999). Protein kinase
C (PKC) can bind to DAG and inhibit PLC, which results in less production of IP3
(Nishizuka, 1988). Thus, the interplay between PKC-regulated PLC and SERCA es-
tablishes a calcium dynamic in the cell. Computational modeling and in vitro studies
4have demonstrated that dierent levels of these regulatory proteins can establish a
range of calcium dynamics from stable levels to oscillations to spiking patterns with
varying frequencies (Bobe et al., 2011; Dolmetsch et al., 1998; Kang and Othmer , 2007;
Schuster et al., 2002). Thus, calcium can serve as a tunable medium for regulating
cell behaviors.
In cardiac muscle, resting polarization of the membrane potential leads to acti-
vation of a slowly depolarizing sodium-potassium current which activates a voltage-
gated calcium current inux and calcium-induced-calcium release of additional cal-
cium from the sarcoplasmic reticulum into the cytoplasm to drive muscle contraction
(Berridge et al., 1999; DiFrancesco, 2006; Nerbonne and Kass , 2005; DiFrancesco,
1985; Bers , 2000). The calcium is cleared and potassium euxes from the cell to
repolarize. The SERCA pump is critical for this periodic contractility by removing
cytosolic calcium (Bers , 2000; Sanyal et al., 2006; Periasamy et al., 1999).Without
sequestration of calcium by SERCA, high levels of calcium in the cardiac cell inacti-
vate voltage-gated calcium and potassium channels, and periodic contractions cease
(Sanyal et al., 2005).
In skeletal muscle activation, SERCA serves a similarly important role in regu-
lating and maintaining repeated muscle contraction. SERCA expression in motor
nerve terminals is necessary for synaptic plasticity and controls the quantal size
of neurotransmitter release (Freeman et al., 2010). In skeletal muscle, SERCA is
essential to sequester calcium following action potential-induced contraction to enable
muscle relaxation and prepare for subsequent stimulation. Loss of SERCA activity
5IP3RSERCA
PIP2
PLC
IP3
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DAG
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Endoplasmic Reticulum
Figure 1.1: The balance between PKC-regulated release of calcium and SERCA re-
turning cytosolic calcium to the endoplasmic reticulum (ER) determines intracellular
calcium dynamics. PKC-regulated PLC generates IP3 which stimulates release of
stored calcium, and SERCA enables repeated release of calcium by pumping it back
into the ER to replenish the store. The relative activities of these opposing operations
can result in dierent patterns and frequencies of calcium ux.
6results in contracted muscle paralysis that is dependent on nerve-induced stimulation
(Sanyal et al., 2005). Thus, SERCA is a critical modulator of calcium dynamics that
underpin periodic muscle contractility, yet its function is not limited to muscle.
1.3 SERCA expression and disease associations
In mammals, SERCA pumps are encoded by three genes, and dierent splice isoforms
of these genes are expressed in dierent tissues (East , 2000). SERCA1a is expressed
in fast-twitch skeletal muscle, 1b in neonatal muscle, 2a in cardiac muscle, 2b in all
cell types for housekeeping functions, and isoform 3 is expressed in various subsets
of cells, including endothelial cells and secretory tissues (Misquitta et al., 1999; East ,
2000; Berridge et al., 1999). Drosophila possess only one SERCA gene, and zebrash
possess three (Sanyal et al., 2005;Magyar et al., 1995; Gleason et al., 2004; Strausberg
et al., 2002). Mutations in SERCA genes result in cardiac dysfunction (Sanyal et al.,
2006; Periasamy et al., 1999; Qi et al., 1997) and skeletal muscle paralysis (Sanyal
et al., 2005). SERCA dysfunction is associated with a range of disorders resulting in
cell stress, tissue remodeling, inammation, and apoptosis, including cystic brosis,
lung brosis, asthma, lung cancer, and diabetes (Ahmad et al., 2009; Korfei et al.,
2008; Lawson et al., 2011; Tanjore et al., 2012; Cantero-Recasens et al., 2010; Mahn
et al., 2009; Korosec et al., 2006; Schroedl et al., 2009; Kono et al., 2012; Ravier et al.,
2011; Takada et al., 2012; Zherebitskaya et al., 2012). SERCA function therefore
underlies the normal basal activity of many cell types and is important for proper
tissue function.
71.4 SERCA regulates fungal hyphal tip growth
Regulation of intracellular calcium levels has been shown to direct cell polarization,
growth, and branching in fungi (Brand et al., 2007; Virag and Griths , 2004; Jackson
and Heath, 1993; Robson et al., 1991a). Indeed, maintenance of a steep calcium
gradient at the tip of growing hypae is essential for hyphal projection and cytoskeletal
rearrangement (Levina et al., 1995; Robson et al., 1991b; Virag and Griths , 2004).
Intracellular calcium sequestration in the endoplasmic reticulum by the SERCA pump
is responsible for establishing this tip calcium gradient, and inhibition of SERCA
abolishes this calcium gradient, disrupts the hyphal cytoskeletal actin network, and
prevents hyphal outgrowth (Silverman-Gavrila and Lew , 2001). Hyphal extension
activates other calcium modulators to reinforce the tip growth (Silverman-Gavrila
and Lew , 2003). Transient release of calcium into the cytosol results in cytoskeletal
contraction and initiation of a new hyphal branch (Grinberg and Heath, 1997; Regal-
ado, 1998; Robson et al., 1991b). This intrinsic role of calcium in fungal branching
suggests that calcium dynamics may also feature in the regulation of branching in
other organisms.
1.5 Periodic peristalsis during lung development
During embryonic lung development, mammalian and avian lungs undergo sponta-
neous peristaltic contractions that commence after the rst few rounds of branching
and increase in frequency near term (Lewis , 1924; Schopper , 1935; Jesudason et al.,
82006; Wilson et al., 2007). These contractions propel lumenal uid through the
bronchial tubules and induce stretch at distended tubule tips (McCray and Joseph,
1993; Schittny et al., 2000). Mechanical distension is necessary for lung growth
and morphogenesis, as manifest by resulting hypoplastic lungs following drainage of
lumenal uid or demuscularization, compared with accelerated growth and matura-
tion of lungs with increased distension from tracheal occlusion (Harding and Hooper ,
1996; Carmel et al., 1965; Agostoni , 1959; Tseng et al., 2000; Wilson et al., 1993).
Mechanical stretch can result in cell signaling and modulation of the cytoskeleton
(Liu et al., 1996). Furthermore, inhibiting the peristaltic lung contractions in vitro by
blocking voltage-gated calcium channels results in lungs with reduced volume but the
same number of buds (Roman, 1995; Jesudason et al., 2005; Jesudason, 2007). This
block in lung growth is not rescued by additional FGF10 growth factor (Jesudason
et al., 2005). Thus, an inux of extracellular calcium is necessary for cell proliferation
to increase total lung volume but is not necessary for continued lung branching.
However, Featherstone et al. (2005) demonstrated that spontaneous calcium waves
propagating through bronchial airway smooth muscle connected by gap junctions
precede and drive these spontaneous contractions. Furthermore, extracellular calcium
entry is required to maintain intracellular calcium stores, and calcium release from the
sarcoplasmic reticulum raises cytosolic calcium levels and generates the propagating
calcium waves. Without these calcium waves traveling through electrically linked
airway smooth muscle, peristalsis ceases. Finally, blocking the activity of the SERCA
pump abolishes the peristaltic contractions as baseline cytosolic calcium levels rise,
9resulting in tonic airway contraction. Upon removal of the SERCA inhibitor, the
paralysis relaxes and calcium waves followed by peristaltic airway contractions resume
(Featherstone et al., 2005). Importantly, during this block in peristalsis from SERCA
inhibition, airway branching halts completely and resumes upon reinitiation of airway
peristalsis (Jesudason, 2007). Therefore, calcium dynamics underlie the peristaltic
activity of developing embryonic lungs and play a role in regulating lung branching.
1.6 SERCA in mammalian lung peristalsis
The importance of lung peristalsis for proper lung growth and maturation prompted
further investigation of the role of calcium dynamics for branching during develop-
ment. Eects on mammalian lung branching were measured for varying levels of
inhibition of SERCA activity. The fungal toxin cyclopiazonic acid (CPA) is a highly
specic inhibitor of all forms of SERCA protein but does not inhibit mitochondrial F1,
sodium-potassium, or other cellular ATPases (Seidler et al., 1989). In lungs explanted
from embryonic day 13 (E13) rat embryos, lungs cultured with varying doses of CPA
or no CPA show a dose-dependent reduction in the rate of branching with increasing
doses of CPA (Fig. 1.2A) (Lansdale et al., 2010). In parallel, lung peristalsis is reduced
with increasing concentrations of CPA (Fig. 1.2B). At the same dose of CPA that halts
branching, peristalsis is abolished. Upon removal of SERCA inhibition, peristalsis
resumes. Lung peristalsis and branching are regulated in parallel by SERCA activity.
Recovery of peristalsis following removal of SERCA inhibition suggests that lung
branching might also resume. In E13 rat lungs cultured for three days with CPA,
10
Days in Culture
B
u
d
s
 p
e
r 
L
u
n
g
 E
x
p
la
n
t
(m
e
d
ia
n
, 
9
5
%
 C
.I
.)
[CPA]
0 µM
4 µM
10 µM
20 µM
0 4 10 20 0
Washout
[CPA], µM
W
a
v
e
s
 p
e
r 
1
0
m
in
, 
4
th
 D
a
y
(m
e
d
ia
n
, 
9
5
%
 C
.I
.)
A B
Figure 1.2: Mammalian lung branching depends on SERCA activity in a dose-
dependent manner. (A) Explanted rat lung buds are cultured with varying doses of
SERCA inhibitor CPA, or without CPA, and the number of buds counted each day for
3 days of culture. The rate of lung branching decreases in a dose-dependent manner
with increasing concentration of CPA. At a concentration of 20M CPA, branching is
halted completely. (B) Explanted lungs are cultured with increasing doses of CPA for
four days, or lungs are cultured with 20M CPA for one day followed by three more
days of culture without CPA, and on the fourth day the number of peristalses per
minute are quantied. Lung peristalsis decreases dose-dependently with an increase
in SERCA inhibition, and peristalsis rebounds following removal of inhibition. Error
bars represent 95% condence intervals.
branching remains suppressed. However, when CPA is removed after one or two
days and the lungs are cultured without SERCA inhibition for the duration of the
three days, branching is restored at approximately the same rate as in lungs cultured
without inhibitor (Fig. 1.3A) (Lansdale et al., 2010). Furthermore, branching resumes
at the point it was halted in the stereotyped budding sequence. In E13 rat lungs
explanted with the same initial number of buds, for each day of SERCA inhibition, the
next bud due to form is delayed by one day (Fig. 1.3B). Thus, blockade of branching
by SERCA inhibition is reversible, and the onset and rate of branching are controlled
by SERCA activity.
These studies of SERCA function in mammalian lung branching demonstrate that
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Figure 1.3: Lung branching resumes at the normal rate where it left o in the budding
sequence when SERCA inhibition is removed. (A) E13 rat lungs are cultured for three
days with the SERCA inhibitor, CPA, for 0, 1, 2, or 3 days. No branching occurs
while CPA is present, but upon washout of CPA after 1 or 2 days, lung budding
resumes at approximately the same rate as in uninhibited controls lungs. (B) E13
rat lungs are explanted with the same number of buds and cultured for 3 days with
dierent durations of SERCA inhibition. With no inhibition, the next bud to form
elaborates after one day, and for each day of SERCA inhibition, that same bud forms
a day later.
cellular calcium dynamics regulated by SERCA activity govern both lung peristaltic
activity that is important for lung growth and maturation and the rate and onset
of lung branching. The continuation of branching that is seen with blockade of
extracellular calcium inux (Roman, 1995) can be explained by the persistence of
SERCA activity and demonstrates that intracellular calcium dynamics involving
regulation of calcium stores in the endoplasmic reticulum govern the onset and rate
of branching. Budding is independent of extracellular calcium, although total lung
volume depends on extracellular calcium, at least in vitro.
The nding that the SERCA pump, which regulates intracellular calcium levels
and sequestration in the endoplasmic reticulum, directs lung branching raises the
question of whether SERCA might serve to regulate branching in vivo and across
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dierent species and tissue types. To determine whether SERCA's regulation of
calcium dynamics is a generalized mechanism conserved through evolution to regulate
budding or bifurcation decisions, I undertook a comparative analysis of SERCA
function in dierent organisms and tissues.
Using Drosophila tracheal and neural development and zebrash intersomitic vas-
cularization, I investigated the importance of SERCA function for budding decisions
in vivo in processes that depend dierently on cell shape changes, cell migration, and
proliferation to determine whether SERCA activity serves as a general mechanism
that regulates budding decisions and to determine which cellular behaviors SERCA
regulates.
1.7 Drosophila tracheal development
The tracheal system is a bilaterally symmetric network of epithelial tubules inDrosophila
melanogaster that delivers oxygen to all body tissues (Wigglesworth, 1972). This
respiratory network forms in the embryo by initial proliferation of progenitor cells at
thoracic and abdominal segments (from T2 to A8), forming paired clusters of cells on
both lateral sides of the embryo (Samakovlis et al., 1996a; Manning and Krasnow ,
1993). These approximately 80 cells per hemisegment form a sac that invaginates
but remains attached to the epithelial surface for air entry (Samakovlis et al., 1996a;
Aolter and Caussinus , 2008). The cells cease to divide and migrate to form a
stereotyped segmental structure with 6 primary branches, including the spiracular
branch that projects to the epidermal surface. FGF/FGFR signaling directs this cell
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migration to generate the branched tracheal network (Sutherland et al., 1996; Klambt
et al., 1992; Glazer and Shilo, 1991; Lee et al., 1996).
Cells forming the dorsal and lateral trunks migrate and fuse with partner cells
in the adjacent tracheal segments (Tanaka-Matakatsu et al., 1996; Samakovlis et al.,
1996a,b). Intercellular junctions connect the cells of the dorsal trunk, where pairs
of cells connect to form the circumference of the tube. Cell intercalation results in
smaller branches like the lateral trunk, where a single cell forms the circumference
of the tube (Ribeiro et al., 2004). These cells have an intracellular junction with
themselves. Secondary branches form at the ends of primary branches, and these
are made of unicellular tubes. The terminal branches that extend to all tissues of
the embryo to deliver oxygen consist of cellular projections without junctions that
lumenize for oxygen transport. A chitin matrix is secreted to stabilize and support the
tracheal lumen, and then lumenal proteins must be cleared for air transport (Araujo
et al., 2005; Tsarouhas et al., 2007; Wang et al., 2006; Devine et al., 2005).
The resulting structure of the tracheal system is highly stereotyped, with bilateral
fused dorsal and lateral trunks, dorsal branches, transverse connectives, spiracular
branches, visceral branches, and ganglionic branches (see Figure 1.4). Dorsal branches
from each side of the embryo fuse to connect the left and right side networks. Through
Drosophila metamorphosis the tracheal system is remodeled to form the series of
tubules and air sacs for respiration in the adult y. Studying formation of the
embryonic Drosophila tracheal system enables in vivo analysis of processes that
depend on cell shape changes and cell migration without proliferation. The tracheal
14
Dorsal trunk
Dorsal branch
Lateral trunkTransverse connective
Ganglionic branch
Visceral branch
Spiracular branch
Figure 1.4: The stereotyped structure of embryonic Drosophila trachea. The diagram
indicates the primary branches that form the stereotyped structure of embryonic
Drosophila tracheal tubules. Anterior to the left, dorsal up.
system is also homologous to the mammalian lungs, but the less complicated genetics
simplies studies.
1.8 Drosophila neural development
Nervous system development in Drosophila is highly stereotyped, with approximately
100 neural lineages, each of which arises from a single neuroblast and innervates
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specic targets (Spindler and Hartenstein, 2010). The ventral nerve cord of the insect
is like the vertebrate spinal cord and consists of cell bodies and structured nerve tracts
along which axons travel (Nambu et al., 1993; Arendt and Nubler-Jung , 1999). Early
in the neuroectoderm, glial cells position in distinct locations and serve as a scaold for
the formation of neural tracts (Hidalgo et al., 1995; Hidalgo and Booth, 2000; Jacobs
and Goodman, 1989; Klambt and Goodman, 1991; Hartenstein and Campos-Ortega,
1984). Specic nerve cells along the ventral neuroectoderm activate expression of
Fasciclin II (FasII), an adhesion molecule homologous to vertebrate N-CAM (Nassif
et al., 1998). These cell bodies form a substratum that outlines where the axon tracts
of the nerve cord will travel. These FasII-positive neurons extend pioneer axons which
also express FasII, adhere to, and are guided by the cell bodies and glial cells to form
the innermost of the three FasII bundles of the longitudinal tracts of the nerve cord
that form on either side of the midline (Nassif et al., 1998; Kuzina et al., 2011).
Follower axons are guided along these tracts by FasII expression and other adhesion
molecules (Sanchez-Soriano et al., 2007).
Guidance of axons across the midline at specic commissures is governed by
attractive and repulsive signals such as netrins from the midline (Bhat , 2005; Harris
et al., 1996; Therianos et al., 1995; Kennedy et al., 1994; Klambt et al., 1991; Mitchell
et al., 1996; Sun et al., 2000). Growth cones of nerves that express the commissureless
gene decrease expression of Robo receptors and are not repelled by midline Slit ligand
until they cross the midline, turn o commissureless, and activate Robo, which
prevents re-crossing (Keleman et al., 2002; Kidd et al., 1998; Parsons et al., 2003;
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Sanchez-Soriano et al., 2007; Tear et al., 1996; Thomas , 1998). Certain cell axons do
not express commissureless and thus remain ipsilateral due to Robo responding to
Slit and negating attractive signals from the midline (Bhat , 2005; Seeger et al., 1993).
The combination of Robos and Robo receptors expressed determines which of the
three lateral tracts the axons follow (Bhat , 2005; Simpson et al., 2000; Rajagopalan
et al., 2000).
The tracts and commissures give rise to the ladder-like ventral nerve cord, and
bilateral segmental and intersegmental motor nerves extend axons to the periph-
ery (refer to Figure 1.5). Axons of other neural lineages use the FasII tracts for
guidance to their respective targets (Sanchez-Soriano and Prokop, 2005; Lin et al.,
1994). Complex migration and guidance decisions are required to orchestrate nervous
system development in Drosophila. Regulation of calcium dynamics may impact the
elaboration of axon tracts and projections.
1.9 Zebrash vascular development
In zebrash embryos, endothelial progenitor cells arise from the lateral plate meso-
derm (Weinstein, 2002; Zhong et al., 2001). Migration of cells to the midline forms
the dorsal aorta and posterior cardinal vein, where the endothelial cells continue to
proliferate (Chittenden et al., 2006). Beginning around 20 hours post-fertilization,
the bilateral intersomitic blood vessels form sequentially in an anterior-to-posterior
direction by individual endothelial cells migrating from the dorsal aorta and posterior
cardinal vein, alternating artery and vein at each division between somites (Siekmann
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Longitudinal fascicles
FasII
Segmental, intersegmental nerves
Commissures
Figure 1.5: The Fasciclin II (FasII) CNS tracts and peripheral nerves. The diagram
illustrates the parallel, bilateral triplets of FasII labeled neural tracts that extend
through the ventral nerve cord, with commissural connections between them. FasII-
positive segmental and intersegmental nerve axons project to peripheral targets.
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and Lawson, 2007). On both sides of the embryo, three or more cells migrate in suc-
cession between adjacent somites and then form intercellular junctions between them
(Siekmann and Lawson, 2007; Childs et al., 2002). The endothelial cells lumenize by
exocytosis and merging of vacuoles between overlapping endothelial cells to form a
continuous tube that joins to larger vessels (Kamei et al., 2006; Blum et al., 2008).
The tip cell at the most distal reach of the vessel extends projections and contacts
tip cells from adjacent intersomitic vessels on the same lateral side of the embryo.
These tip cells fuse to form the longitudinal anastomotic vessel that runs dorsal to
the somites (Isogai et al., 2001). See Figure 1.6 for a simplied diagram of zebrash
vasculature at the stage of interest.
Cell division may, or may not, occur in a non-stereotyped manner during in-
dividual intersomitic vessel outgrowth, but cell migration plays an invariant and
prominent role in formation of the zebrash intersomitic vasculature (Siekmann and
Lawson, 2007; Blum et al., 2008; Childs et al., 2002). Zebrash intersomitic vascular
development permits characterization of the in vivo role of SERCA function in a non-
epithelial tissue where predominantly migration, and some dispersed proliferation,
generate a branched structure.
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Intersomitic vessel
Dorsal longitudinal
anastomotic vessel
Dorsal aorta
Posterior cardinal vein
Figure 1.6: The vascular structure of the 28 hour post-fertilization (hpf) zebrash
embryo. The diagram shows the wild type structure of the intersomitic and trunk
vasculature of the 28 hpf zebrash embryo.
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Chapter 2
Methods
2.1 Zebrash intersomitic vasculature studies
Transgenic Tg(kdrl:eGFP) zebrash with the VEGF receptor promoter driving eGFP
expression express eGFP in endothelial cells. These sh were crossed with wild type
sh and embryos were collected and incubated until 21 hours post-fertilization (hpf).
eGFP positive embryos were sorted and dechorionated. Embryos were incubated with
cyclopiazonic acid (CPA) (Sigma 1530) or DMSO from 22 hpf until 28 hpf in 1.5 mL
of egg water. CPA was applied at concentrations of 1.25M, 5M, 10M, or 20M.
For drug washout studies, embryos were incubated in 10M or 20M CPA for 2 hours,
then rinsed 3 times in egg water and incubated for the remaining 4 hours without
drug. After 6 hours of incubation, embryos were rinsed 3 times in egg water and
xed overnight at 4 degrees C in 4% PFA. To collect wideeld images, embryos were
positioned on top of methylcellulose. For confocal imaging, embryos were mounted
on coverslip-bottomed imaging dishes in 1% agarose molds and covered with 1% low-
melting point agarose. Imaging was performed with a Zeiss LSM 510 meta microscope.
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Tiled z-stacks were collected with the following image collection parameters: 488nm
laser excitation, 2m pinhole, 2m z-step interval. Z-stacks were assembled, and
Imaris software (Bitplane) was used to generate 3D images and measure intersomitic
vessel branches, lengths, and height in three dimensions to quantify the eects of
CPA on intersomitic vessel growth and branching.
Data plots for vessel count, height, length, and branching were generated using
python code (courtesy of Daniel J. Bower). Graphs for the rate of branching and cell
migration were produced using MATLAB.
2.2 Drosophila embryo collection and drug treat-
ment
Drosophila embryos were collected in egg-laying chambers for three hours. Fly lines
used are listed in Table 2.1. Embryos were dechorionated in 50% bleach for 2 minutes
and rinsed in tap water. Embryos were then transferred to nylon cell strainers (BD
Falcon 2360) and permeabilized with permeabilization solvent (90% D-limonene, 5%
cocamide DEA, 5% ethoxylated alcohol) as previously described (Rand et al., 2010).
This embryo permeabilization solvent (EPS) was diluted 1:10 into modied basic
incubation medium (MBIM) for treatment of the embryos as described by Strecker
et al. (1994); Rand et al. (2010) except that the malic acid was not added to the
solution (see Table 2.2. Embryos were permeabilized for 30 seconds, washed 4 times
in PBS and twice in PBS+0.05% Tween20 and distributed onto nylon cell strainers
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Table 2.1: Genotypes of y lines used.
Description Genotype
Wild type w
Tracheal actin-eGFP, nuclear dsRed w; Btl:Gal4, UAS-dsRed-nuclear localization
signal, UAS-actin-eGFP
Tracheal GCamp3 Btl:Gal4, UAS-GCamp3/CyO
Table 2.2: Composition of modied basic incubation medium (MBIM) (1 liter in
milli-Q water). pH adjusted to 6.8 with NaOH and KOH and sterile ltered.
Component (grams)
MgCl2 6H2O 2.2
MgSO4 7H2O 2.97
NaH2PO4 0.42
Glutamic Acid 12.1
Glycine 6.05
Sodium Acetate 0.027
Glucose 2.2
CaCl2 2H2O 0.99
or Whatman paper for incubation. Embryos were incubated on cell strainers or
Whatman paper in 6 well dishes in contact with drug (20M CPA, 100nM PMA) or
DMSO diluted in MBIM until they reached stages 13 to 16 by gut morphology. For
washout experiments, the drug solution was removed at stage 12 and the embryos
were rinsed and then incubated for the remainder of the time in MBIM without drug.
2.3 Drosophila embryo xation
For whole mount preparation, when embryos reached stages 13 to 16, they were
transferred to glass vials and treated with heptane and 5% PFA in PBS for 15 minutes
at room temperature to x. The PFA was removed and 100% methanol was added,
and the embryos were shaken to remove the vitelline membrane. The heptane was
aspirated and the embryos were incrementally rehydrated through 70%, 50%, 30%,
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0% methanol in PBS and then transferred to PBT (PBS + 0.05% TritonX-100 +
0.1% BSA).
2.4 Drosophila embryo antibody staining
For antibody staining, embryos were blocked for 1 hour at room temperature in 5%
normal goat serum (NGS) then incubated with primary antibodies in PBT + 2%
NGS overnight at 4 degrees C. Embryos were washed 6 times for 30 minutes at room
temperature in PBT then blocked for 20 minutes in 5% NGS. Secondary antibodies
(Invitrogen) were used at 1:500 in PBT + 2% NGS overnight at 4 degrees C. Embryos
were washed 6 times for 30 minutes at room temperature and transferred to PBT/14%
glycerol then mounted on glass slides with permauor and coverslipped for imaging.
Fillet preparations were performed as previously described (Lee, 2009). Briey,
following drug treatment embryos were spread on glass slides with guts removed and
a wax line drawn around them on the slide. They were xed in 5% PFA for 30
minutes at room temperature and washed 4 times for 5 minutes in PBS and again
in PBT on the slides. Blocking was performed for 30 minutes in 5% NGS, and llets
were incubated with primary antibodies as above at 4 degrees overnight. Fillets were
washed 6 times for 10-30 minutes and incubated with secondary antibodies as above
at 4 degrees overnight, then washed again 6 times for 10 minutes. Coverslips were
mounted and sealed with nail polish. Confocal and two-photon tiled z-stacks were
collected with a Zeiss LSM 510 meta microscope with a 2m pinhole (for confocal) and
1.5m z-step interval. Images were assembled using Fiji stitching plugins (Preibisch
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Table 2.3: Antibodies used to stain Drosophila embryos. (DSHB) Developmental
Studies Hybridoma Bank.
Target Dilution Host Animal and Isotype Manufacturer Catalog #
Tracheal lumen 1:2 Mouse IgM DSHB 2A12
Fasciclin II 1:3 Mouse IgG1 DSHB 1D4
eGFP 1:1000 Rabbit IgG Abcam AB290
et al., 2009) and viewed in 3D using Imaris software (Bitplane).
2.5 Dynamic imaging of Drosophila embryos
Drosophila embryos from the transgenic line w; Btl:Gal4, UAS-dsRed-NLS, UAS-
actinGFP were collected and permeabilized as described above. Embryos were treated
with DMSO (control) or 20M CPA and screened for uorescence around gut stage
12 to 13. Fluorescent embryos were mounted lateral side down either on glass
coverslips with heptane glue and imaged with the incubation medium serving as
the objective immersion uid, or they were mounted in coverslip-bottomed dishes
in 1% agarose molds. The latter were covered with 1% low-melting point agarose
and incubation medium and imaged through the coverslip with water immersion uid
to minimize refractive index mismatch. A high-numerical aperture, long-working-
distance water immersion objective (LD-C-Apochromat 40X/1.1W Korr UV-VIS-IR)
was used. Direct contact imaging requires thoroughly cleaning the objective of all
traces of immersion oil. The embryos were imaged on a Zeiss LSM 510 meta or Zeiss
LSM 5 Exciter confocal microscope with 488 nm and either 543 or 561 nm lasers.
318x318x64m z-stacks were collected with 0.62x0.62x2m3 voxel size, and a stack
was collected every 3 to 3.5 minutes.
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2.6 Processing of dynamic imaging datasets
Datasets were compiled and registered using Imaris 7.6 (Bitplane). Individual cells of
the tracheal lateral trunk that are destined to migrate to connect the trunk between
segments were manually tracked in 3D from stage 14 to early stage 16. Positions
of the tracked cells over the timecourse were exported to MATLAB. The separation
between pairs of cells in adjacent segments that should migrate together to form the
trunk were measured at the start and end to determine the relative convergence of
the pair of cells, for DMSO-treated and CPA-treated embryos. Similarly, the overall
direction of movement of one cell in the pair relative to the other was calculated
and plotted to collectively visualize the directional migration of all pairs for each
treatment.
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Chapter 3
SERCA governs zebrash vascular
development by regulating cell
migration
To determine the role of SERCA activity in the outgrowth and branching of zebrash
vasculature, zebrash embryos were exposed to SERCA inhibitor during intersomitic
vessel development. From 22 to 28 hours post-fertilization (hpf), after the rst
approximately four vessels had begun to form, embryos were incubated with increas-
ing doses of the highly specic, pan-SERCA inhibitor, cyclopiazonic acid (CPA).
Wideeld images of embryos reveal that the overall morphology of the embryo is
aected with CPA treatment (Fig. 3.1). The DMSO-treated control displays wild
type morphology with a planar body alignment and straight dorsal aorta (vasculature
indicated in green) (Fig. 3.1A). The embryos treated with CPA have more limited
tail growth and exhibit a curved and twisted body (Fig. 3.1B,D). Increasing doses
of CPA increases the severity of kinks in the dorsal aorta and posterior cardinal
vein. Individual intersomitic vessels also appear stunted. Removal of CPA after 2
hours and incubation for the remaining time without the SERCA inhibitor broadly
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Figure 3.1: CPA aects zebrash embryo morphogenesis but not eGFP expression.
Zebrash embryos were treated with specic SERCA inhibitor, CPA, during inter-
somitic vessel development. Overall morphology is normal in (A) DMSO-treated
embryos (control). Increasing doses of CPA causes progressive twisting of the body
axis, kinking of the dorsal aorta, and stunting of intersomitic vessel outgrowth in (B)
10M and (D) 20M. (C and E) Washout of the drug 2 hours into the incubation
improves tail and blood vessel morphology. eGFP expression (green) is not aected
by drug treatment. (CPA, cyclopiazonic acid)
improves intersomitic vessel outgrowth and tail structure, particularly for the lower
dosage of CPA (Fig. 3.1C,E). Importantly, comparable eGFP uorescence is seen
throughout the head vasculature and dorsal aorta, indicating that GFP expression
itself is not aected by SERCA inhibition, and therefore the rudimentary appearance
of the intersomitic vessels is due to stunted outgrowth rather than lack of GFP
expression. Thus, application of a SERCA inhibitor aects embryo development,
and the eects on the intersomitic vasculature can be quantied.
To quantitatively investigate the eects of SERCA inhibition on vascular devel-
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opment, Flk1:eGFP transgenic embryos expressing eGFP in all endothelial cells were
imaged with confocal microscopy, and the tail and intersomitic vasculature were
reconstructed in 3D. Figure 3.2A shows a wideeld image of a wild type embryo
and outlines the region of interest of vessels that formed during the incubation period
with or without SERCA inhibitor. This region was imaged at higher resolution and
reconstructed. In control DMSO-treated embryos, parallel intersomitic vessels project
from a straight dorsal aorta and posterior cardinal vein (Fig. 3.2B). Cell nuclei are
visible along the length of vessels with increased density of eGFP localization. At the
tips of the intersomitic vessels, cells have extended longitudinal projections towards
adjacent vessels to fuse and form the longitudinal anastomotic vessel dorsal to the
somites. Younger, more posterior vessels (towards the right) have not yet grown to
full length, and cell nuclei have not yet reached the tip of the vessel. Increasing doses
of SERCA inhibitor from 1.25M to 20M (Fig. 3.2C-E,G) induces increasingly severe
curvature of the dorsal aorta and posterior cardinal vein and truncated intersomitic
sprouts. While the vessels look relatively normal with 1.25M CPA (Fig. 3.2C),
and the dorsal aorta is only a bit curved with 5M CPA, the tail and vascular
structure are contorted with higher doses (Fig. 3.2E,G). Removal of 10M CPA after
2 hours of the incubation period ameliorates vascular development (Fig. 3.2F). The
tail vasculature is less kinked, and the intersomitic sprouts are longer and greater in
number. There are no gaps or 'skipped' intersomitic sprouts, indicating that upon
removal of the inhibitor, growth resumes from the stage it was at and proceeds in
the normal anterior-to-posterior direction. Thus, inhibition of SERCA slows the rate
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of growth such that fewer vessels have formed compared with controls during a xed
amount of time. But this inhibition is reversible, and vascular development proceeds
normally with inhibitor washout. Quantitation is necessary to determine the dose
dependence. Washout of the 20M CPA results in less obvious recovery of vascular
development that also requires quantitation to identify (Fig. 3.2H).
The 13th through 16th, 19th, and 20th sprouts from the anterior end were com-
pared across treatment with DMSO (control), increasing doses of SERCA inhibitor,
and washout of inhibitor after 2 hours. Figure 3.3A shows an overview of the
intersomitic vasculature formed during the incubation period and the locations of the
individual sprouts 14-15 and 20 depicted in the paired images in B-H. Figure 3.3B
displays the typical height and morphology of sprouts in DMSO-treated controls.
Three to four cells comprise each of the more mature sprouts, and a cell nucleus is
frequently positioned at the distal tip, as indicated by the red arrow. At the end of
the incubation period, the 20th sprout is still forming, but cytoplasmic projections
extend the sprout to a considerable height.
With increasing concentrations of SERCA inhibitor, the intersomitic sprouts that
formed during the middle of the incubation period (sprouts 14-15) and near the end
of the incubation period (sprout 20) are shorter and less branched (Fig. 3.3C-E,G).
The red arrow in Fig. 3.3E indicates the position of the nucleus of the cell that has
migrated the furthest along the vessel. It is situated in the middle of the sprout
rather than at the tip. When the SERCA inhibitor is removed after 2 hours and the
embryos incubated without drug for the remainder of the time, growth and branching
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Figure 3.2: SERCA inhibition aects tail vessel morphology and outgrowth. The
intersomitic vessels that formed during SERCA inhibition in Flk1:eGFP transgenic
embryos were imaged with confocal microscopy and reconstructed in 3D to visualize
the impacts on vascular development. (A) The wideeld image of wild type embryo
shows the vessels formed during the incubation period (scale bar=200m). Panels
B-H show 3D reconstructions of confocal images of intersomitic vasculature from
embryos treated with (B) DMSO (control), (C) 1.25M, (D) 5M, (E) 10M, (G)
20M CPA, or CPA washed out 2 hours into the incubation (F) 10M washout, (H)
20M washout (B-H, scale bars=100m). In controls, the intersomitic vessels extend
to the tips of the somites where the vessels branch to fuse with their neighbors.
Increasing the dose of SERCA inhibitor increases the severity of dorsal aorta
contortion and progressively stunts the outgrowth and branching of the intersomitic
vessels. Washout of the inhibitor lessens the severity of the phenotype, and growth
resumes from the point it was at when inhibition is released, rather than skipping
sprouts.
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resume. The sprouts depicted in Fig 3.3F and H are longer with more buds than their
counterparts in Fig. 3.3E and G which were exposed to drug for the duration of the
six hours. This resumption of growth following release of SERCA inhibition indicates
that vascular sprouting and elongation are reversibly on hold when the SERCA pump
is blocked. Quantication of outgrowth and branching reveals the extent of growth
inhibition and recovery.
The growth dimensions and number of branches were measured for individual
intersomitic sprouts formed during the incubation period to quantify the growth
and branching eects of SERCA inhibition. The composite length of all branches
per sprout, radial height of the sprout from the dorsal aorta, number of branches
per sprout, and total number of sprouts that formed per embryo were measured
in three dimensions for zebrash embryos incubated with DMSO, increasing doses
of SERCA inhibitor, or embryos with drug washed out after 2 hours. Figure 3.4A
shows the total number of intersomitic vessels that formed per embryo for each of the
treatment groups. Red lines indicate the median value. Typically 23 or 24 vessels
form by 28hpf in control embryos treated with DMSO, and the number decreases
as SERCA inhibition increases. Approximately 15 vessels form in embryos treated
with 20M CPA. Following washout of inhibitor, vessel outgrowth increases, albeit
only slightly for the 20M CPA washout embryos. This level of inhibition may be
severe enough that it takes longer for sprouting activity to recover, and the recovery
is slow. In contrast, in embryos treated with 10M CPA washed out after 2 hours, an
equal number of intersomitic sprouts form by the end of the incubation period as in
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Figure 3.3: Caption next page.
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Figure 3.3: Individual intersomitic sprout outgrowth and branching is aected by
SERCA inhibition in a dose-dependent manner. The panels in (A) outline the
specic sprouts detailed in paired panels that form during the middle and end of
the incubation period. Scale bars=200m (wideeld), 100m (inset). Embryos are
incubated from 22 to 28 hpf in the presence of (B) DMSO, (C) 1.25M, (D) 5M,
(E) 10M, (G) 20M CPA, or CPA washed out 2 hours into the incubation (F)
10M washout, (H) 20M washout. SERCA inhibition results in a dose-dependent
reduction in the growth and branching of vessels that form during the middle and
near the end of the incubation period. The extent that individual cell soma have
migrated along the length of the vessel is apparent by increased expression in the
nucleus. Red arrows indicate a cell that has migrated to the tip of the branch in (B),
while in E, the most distally migrated cell is still in the center of the vessel. (F and
H) Growth and branching resume following washout of the inhibitor. Scale bars in
B-H = 50m.
controls treated only with DMSO. Embryos treated for the duration with 10M CPA
form approximately 3 fewer vessels than controls. Thus, the rate of vessel outgrowth
following removal of SERCA inhibitor must be greater than the wild type rate for
some duration of time in order to catch up with the uninhibited embryos. Eects of
SERCA inhibition at lower doses are more subtle by measurement of the number of
vessels formed, but the inhibitory eects are clear when considering the dimensions
and number of buds per vessel.
Figure 3.4B plots the cumulative number of branches, or buds, present on inter-
somitic vessels 13 through 16 for embryos in each treatment group. These vessels
form during the middle of the incubation period after the drug has equilibrated and
should exhibit the full eects of SERCA inhibition. Since the panels in Figure 3.3
show that vessels are shorter with increasing SERCA inhibition, the vessels would
also be expected to have fewer buds. Endothelial cells of the vessels extend cyto-
plasmic projections to form the longitudinal anastomotic vessel connecting their tips
and a parachordal vessel midway between the dorsal aorta and dorsal longitudinal.
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Intersomitic vessels that have not attained their full length would be expected to have
few buds. Indeed, the number of buds that have formed on these vessels decreases
with increasing SERCA inhibition (Fig. 3.4B). Washout of CPA permits increased
budding concomitant with increased vessel length.
To investigate how SERCA inhibition aects the early stages of vessel develop-
ment, the height, length, and number of buds per vessel were quantied for the
19th and 20th vessels, which form near the end of the incubation period in control
embryos and thus are at a younger phase of outgrowth. Figure 3.5A-C plot these
measures for each treatment group for the 19th intersomitic vessel, and Figure 3.5D-
F plot the values for the 20th vessel. Consistent with the data from sprouts 13 to
16, the individual vessel budding (Fig. 3.5A,D), length (Fig. 3.5B,E), and height
(Fig. 3.5C,F) are reduced dose-dependently with SERCA inhibition and partially
rescued with washout of inhibitor. At a concentration of 20M CPA, the 19th and
20th vessels have not yet formed. The median lengths and heights of the 20th vessels in
the 10MCPA washout group are nearly equivalent to the controls. At the point when
these vessels are forming, the drug has been absent for several hours, and the results
suggest that by the formation of the 20th intersomitic vessel, these embryos have
"caught up" with controls in terms of vessel outgrowth. The data also suggest that
the initial stages of outgrowth to form an intersomitic vessel proceed more normally
than budding following CPA washout because there are fewer buds on the 20th vessel
of the 10M washout embryos compared with controls. The 19th vessels also still
have a decit in height, length, and branching compared with the equivalent vessels
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Figure 3.4: The total number of intersomitic vessels and the number of buds on vessels
formed during the middle of the incubation period are reduced dose-dependently with
SERCA inhibition. (A) The number of intersomitic vessels formed per embryo by
28hpf is plotted for each treatment group. Each symbol represents a measurement
from one embryo and the red lines indicate the median values. SERCA inhibition
reversibly reduces the number of branches in a dose-dependent manner. Washout of
20M CPA produces a slight recovery in sprout formation, but washout of 10M CPA
results in complete rescue of the total number of intersomitic vessels that have begun
to form by 28hpf. (B) The collective number of branches or buds on intersomitic
vessels 13 through 16, which form during the middle of the incubation period, are
plotted. The dose-dependent reduction in branching of these vessels with increasing
SERCA inhibition is partially rescued by washout of the inhibitor 2 hours into the
incubation.
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in controls despite the 20th vessels having comparable height and length relative to
controls. So the initiation of migration to form the vessel may be fully recovered but
later migratory activity and cytoplasmic budding may lag behind.
To further investigate the role of SERCA activity in regulating cytoplasmic ex-
tensions, or branching, the rate of branching over time was considered. Since the
vessels form in an anterior-to-posterior wave, the more anterior ones have had more
development time since their initiation than more posterior ones. A comparison
between treatment groups of the number of branches on sequential vessels reects the
rate of branching with time, where higher number vessels are younger. A graph of
the number of branches on the 13th, 16th, and 19th intersomitic vessels for each
treatment group demonstrates a dose-dependent rate of branching with SERCA
inhibition (Fig. 3.6). It also shows that inhibition of the SERCA pump more severely
aects the rate of branching during early stages of vessel formation as the slope of the
line connecting the younger vessels 19 and 16 is reduced with inhibition of SERCA.
The rate of budding at later stages (represented by the line between the 16th and 13th
vessels) is similar across treatment groups, although the total number of branches
is reduced with SERCA inhibition. Thus, cells may be more sensitive to SERCA
inhibition when they are trying to initiate the extension of cytoplasmic projections.
Alternatively, all cellular behaviors are most aected by SERCA inhibition early in
the process of vessel outgrowth, and so most of the delay in migration and branching
occurs then.
Because the intersomitic vessels form by migration of 3 or 4 individual endothelial
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Figure 3.5: Caption next page.
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Figure 3.5: The height, length, and number of branches on intersomitic vessels formed
near the end of the incubation period are reduced in a dose-dependent manner with
SERCA inhibition. (A-C) show plots of the number of branches per vessel, the
composite length, and the radial height, respectively, for the 19th intersomitic vessels
on embryos from each treatment group. (D-F) plot the same measurements for the
20th intersomitic vessels. Median values for each treatment group are indicated by
red lines. All metrics decrease in a dose-dependent manner with increasing SERCA
inhibition. For the 19th intersomitic vessel (A-C), washout of the inhibitor results in
a partial rescue. Washout of the 10M CPA results in a complete rescue of vessel
outgrowth measured by height and length for the 20th intersomitic vessel, but an
incomplete rescue of budding. Initiation of cell migration to form the vessel may be
mostly normal while initiation of cytoplasmic projections may be delayed.
cells from the dorsal aorta or posterior cardinal vein, the positions of nuclei along
the length of the vessel were quantied as a direct measure of cell migration. For the
12th through 14th intersomitic vessels, Figure 3.7 plots the percentage that possess a
cell nucleus at the distal tip of the vessel (refer to Fig. 3.3 for images of cell nucleus
positioning along the vessels). In the DMSO-treated controls, the distal-most cell has
migrated to the tip of the vessel in 66% of the intersomitic vessels. This percentage
declines to 14% in the 20M CPA-treated embryos and recovers to 47% in the
10M CPA washout group with statistical signicance less than 0.05 by Chi-squared
analysis. The graph of the dierent treatment groups mirrors those for the height,
length, branching, and number of intersomitic vessels. Additionally, the reductions
in vessel dimensions are not a result of fewer cells constituting the vessels but rather
result from the positions of the cells within the vessel. This nding indicates that
a defect in endothelial cell migration as a result of inhibition of the SERCA pump
accounts for the observed perturbations in intersomitic vessel growth and branching.
The behaviors of migration of the cell soma and protrusion of cytoplasmic buds are
likely independent, and there may be nuances in the extent to which SERCA regulates
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Figure 3.6: Early stages of vessel growth are more sensitive to SERCA inhibition in
terms of the rate of initiating branches. The intersomitic vessel number is used as
a surrogate for the amount of time a vessel has spent developing since they form in
an anterior-to-posterior sequence. Vessels of higher number are younger. The graph
shows that the rate of branching is more severely reduced by SERCA inhibition early
on in the process of vessel outgrowth: with SERCA inhibition, the slopes of the
lines connecting vessels 19 and 16 are less than those at the later developmental age
between vessels 16 and 13.
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each. However, at a basic level, SERCA's regulation of cell motility explains the dose-
dependent defects in intersomitic vessel growth and budding observed with SERCA
inhibition.
Calcium's regulation of cell behaviors may depend on dynamic patterns of calcium
ux, and the dynamics are governed by the interplay between SERCA activity to
store calcium and IP3-driven release of calcium into the cytoplasm. Because protein
kinase C (PKC) inhibits phospholipase C (PLC) and thus IP3 production, we asked
whether activating PKC in the background of SERCA inhibition could balance the
impaired pumping of calcium to the ER and serve as a partial rescue of intersomitic
vessel growth and branching. A phorbol ester was used to activate PKC and thus
reduce the release of calcium into the cytoplasm by IP3. Addition of PKC activator
alone had an inhibitory eect on intersomitic vessel outgrowth and branching. The
combinatorial treatment of PKC activation plus SERCA inhibition produced results
that were either similar to the SERCA inhibition alone or showed an additive eect
(see data in appendix A).
There are several isoforms of PKC performing many activities in a cell, and it
may be that inhibition of a select one of them would be necessary to rescue the
SERCA inhibition. However, indiscriminate inhibition of multiple isoforms could
perturb many dierent cell behaviors and result in impaired cell motility, which
could be dependent on or independent of calcium. Specic inhibition of individual
isoforms of PKC would be necessary to determine whether PKC activation and IP3
reduction could partially rescue SERCA inhibition. Alternatively, endothelial cell
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Figure 3.7: SERCA-dependent defects in endothelial cell migration account for the
observed impairments in intersomitic vessel outgrowth and branching. Cell migration
was measured by quantifying the percentage of the 12th through 14th intersomitic
vessels in which a cell nucleus was positioned at the distal tip of the vessel, indicating
complete migration of the cell along the length of the vessel. Cell migration is
impaired in a dose-dependent manner with SERCA inhibition and reects the defects
in vessel height, length, branching, and total number of vessels per embryo. A defect
in SERCA-dependent cell motility therefore explains the measured impairments in
intersomitic vessel growth and branching from SERCA inhibition.
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outgrowth and branching to form the intersomitic vessels may require a particular
pattern of changing calcium levels to direct cell motility. Inhibition of both arms
of the calcium cycle{calcium release and calcium uptake{may not reconstitute the
dynamic uctuations necessary for vessel formation.
3.1 Summary
We conclude from these studies of the eects of SERCA inhibition on zebrash inter-
somitic vascular growth that inhibition of SERCA activity impedes vessel outgrowth
and branching. The dorsal aorta and posterior cardinal vein become increasingly
malformed with higher doses of SERCA inhibitor, and the individual intersomitic
sprouts are shorter and possess fewer branches compared with controls after the same
incubation time. The rate of branching earlier in the vessel's formation may be more
severely aected than branching when the vessel is more mature. Vessel outgrowth
and branching decrease dose-dependently with increasing SERCA inhibition, and
the eect is reversed upon removal of the inhibitor. Thus, SERCA's regulation
of calcium serves as a dynamic cue that instructs cell behavior, and the proper
dynamic can resume as soon as SERCA activity is restored. Cell position within
the more developed vessels rather than the number of cells accounts for the measured
dierences. This suggests that impaired cell migration accounts for the reduction in
vessel growth and branching, which is consistent with previous work showing that the
vessels form principally by cell migration (Childs et al., 2002). Activation of PKC
to reduce calcium release into the cytoplasm does not compensate for the impaired
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calcium uptake into the ER to rescue zebrash intersomitic vessel outgrowth.
Zebrash intersomitic vascular development relies principally on the migration
of individual endothelial cells between the somites. Some cell division does occur,
however. While these studies indicate that SERCA-dependent defects in cell migra-
tion give rise to the observed vascular phenotype, we wished to determine whether
cell migration can fully account for SERCA-dependent budding defects. For this
we turned to a system where branching proceeds in the complete absence of cell
proliferation.
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Chapter 4
PKC-regulated SERCA governs
Drosophila tracheal and neural
morphogenesis
To determine whether SERCA regulates branching across tissues and species, and
whether it regulates branching in a system that relies exclusively on cell migration,
we studied SERCA activity in Drosophila embryos. PKC activation was also tested
to see whether it could rescue SERCA inhibition in the context of tracheal and
neural development by reducing ER calcium release. The Drosophila embryonic
nervous system, unlike the zebrash vasculature, depends on both cell migration and
considerable proliferation. In contrast, the embryonic tracheal system is a network of
epithelial tubules that forms exclusively by the migration of individual tracheal cells
following complete cessation of cell proliferation. It is thus a useful system to assay
the extent to which SERCA regulates branching by directing cell migration.
To determine whether SERCA is important for the formation of the embryonic
Drosophila tracheal network and CNS development, embryos were permeabilized and
treated with DMSO (control) or drug through embryonic development. The specic
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pan-SERCA inhibitor, CPA, and protein kinase C activator, PMA, were administered
alone or in combination. Embryos were xed around stage 15 to 16 when the CNS and
tracheal network have formed. Antibody staining for Fasciclin II and tracheal lumen
protein reveal CNS tracts and motor axons, and tracheal structure, respectively.
Figure 4.1 shows whole mount images of embryos treated with (A) DMSO (con-
trol), (B) 20M CPA, (C) M CPA washed out at stage 12 (early organogenesis),
(D) 100nM PMA, and (E) 20M CPA + 100nM PMA. The normal tracheal network
(cyan) is evident in controls (Fig. 4.1A) with interconnected segments and continuous
dorsal and lateral trunks (refer to Fig. 1.4 on page 14 for the names of the dierent
branches). The nervecord can be seen with tracts (magenta) running along the ventral
side of the embryo and axons projecting dorsally alongside segments of the trachea.
The embryo permeabilization does not cause developmental perturbations in controls,
however, it is eective for administering drugs as the tracheal network and nerves are
disrupted with CPA treatment (Fig. 4.1B). The trachea and nerve networks can be
seen for each treatment, albeit with faint dorsal trunk labeling for the washout and
PMA treatments (Fig. 4.1C,D, arrowheads). Of note is the normal-looking embryo
treated with CPA and PMA (Fig. 4.1E) compared with the embryo treated with
SERCA inhibitor (Fig. 4.1B), where the tracheal structure is fragmented. There are
breaks in the dorsal trunk (yellow arrowheads), lateral trunk (blue arrowheads), and
the longitudinal nerve fascicles (pink arrowheads).
A closer look at just the trachea in whole mount embryos labeled with antibody
to tracheal lumen protein shows that compared with controls (Fig. 4.2A), the trachea
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Figure 4.1: Dual label of Drosophila trachea and nerves demonstrates that the per-
meabilization of the embryos itself causes no phenotype but permits drug treatment.
(A) Permeabilized controls treated with DMSO. (B) Embryos treated with SERCA
inhibitor display breaks in the dorsal trunk (yellow arrowheads), lateral trunk (cyan),
and ventral nervecord (pink). (C) Washout of SERCA inhibitor at stage 12 improves
tracheal and nerve networks, although incompletely (arrow). (D) The dorsal trunk is
not visible in embryos treated with PKC activator, but they otherwise look normal.
(D) Dual treatment with SERCA inhibitor and PKC activator normalizes tracheal
and neural structure. Scale bars=50m. 2A12 labels tracheal lumen. FasII marks
longitudinal fascicles and motor axons.
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of the CPA-treated embryo (Fig. 4.2B) is highly disorganized and discontinuous.
The dorsal trunk is absent (yellow arrowheads), and the lateral trunk is severely
fragmented with few connected segments (yellow arrows). In this severe case, the
visceral branches cannot be distinguished from the transverse connectives, and some
of the glial branches appear to be missing (open arrowheads). Following removal
of SERCA inhibitor at stage 12 with drug-free culture to stage 16 (Fig. 4.2C), the
embryo exhibits a relatively normal tracheal network. The dorsal trunk stains faintly
in this particular embryo, which may indicate a defect in lumenization or lumen
protein secretion; however, it is largely continuous except for one gap (arrowhead).
The most striking appearance is the exuberant branching at the tips of tubes of
the visceral branches and glial branches (open arrowheads). Many of the tubes are
have a squiggly structure as though the tube is longer than it needs to be, and the tips
project farther than in controls. These features suggest that removal of the SERCA
inhibitor either resulted in an over-compensatory branching and migration of the cells,
or that these behaviors are normally restrained and that this restraining mechanism
recovered more slowly than SERCA's activity to promote migration upon removal of
the inhibitor. In addition, the gross recovery of tracheal structure following washout
of the inhibitor suggests that the defects are not a result of perturbed extracellular
matrix or other cues that the tracheal cells require in order to migrate to their proper
positions. Instead, the eect is more likely a reversible cell-autonomous defect in
migration, and when inhibition of the SERCA pump is relieved, the cells are able to
resume migration and recover their proper positions. In the embryo treated with PKC
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activator (Fig. 4.2D), the tracheal network appears normal apart from the missing
dorsal trunk (outlined by yellow dots), which is investigated further in Figure 4.3.
In (Fig. 4.2E), the embryo treated with the combination of the SERCA inhibitor
and PKC activator recovers a remarkably normal tracheal structure with continuous
trunks and segmental projections.
Visualizing the Drosophila embryonic trachea using an antibody to tracheal lumen
protein suggests defects in tracheal structure from SERCA inhibition and perturbed
dorsal trunk formation from PKC activation. However, this could be an artifact of
the antibody used if tube lumenization, rather than cell migration to form tubes,
is aected. To ascertain that the observed defects are actual gaps in the tracheal
structure due to mispositioning of tracheal cells, we used a transgenic y line to
genetically label all tracheal cells by the early tracheal-specic promoter Breathless
(Btl). In the w; Btl:Gal4, UAS-dsRed-NLS, UAS-actin-eGFP line, tracheal cell nuclei
are red and eGFP fused to actin labels the outline of the cells. These embryos
were permeabilized and treated with SERCA inhibitor and/or PKC activator as
before and stained with anti-GFP antibody to visualize all tracheal cells regardless
of lumenization.
The panels in Figure 4.3 show images of the trachea from embryos lleted to
remove gut autouorescence. Dashed yellow lines outline the dorsal trunk in each
panel. Tracheal structure is normal in permeabilized embryos treated with DMSO
(Fig. 4.3A), with continuous dorsal and lateral trunks. In embryos treated with
SERCA inhibitor (Fig. 4.3B), complete gaps between segments (arrowhead) and
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Figure 4.2: SERCA inhibition disrupts tracheal morphogenesis and PKC activator
rescues. (A) Control embryos treated with DMSO. (B) Embryos that develop
in the presence of SERCA inhibitor have grossly disrupted tracheal development.
Breaks persist in the dorsal trunk (arrowheads), lateral trunk (arrows), and glial
branches (open arrowheads). (C) Washout of SERCA inhibitor at stage 12 and
continued development in the absence of drug results in exuberant sprouting and long,
wavy tubules (open arrowheads). The overall tracheal structure is vastly recovered,
although a break persists in the dorsal trunk (closed arrowhead). (D) Development
with the PKC activator alone results in an apparently missing dorsal trunk by lumenal
staining but otherwise normal trachea (also see Fig. 4.3. (E) Co-culture with SERCA
inhibitor and PKC activator rescues tracheal development. Scale bars=50m. 2A12
labels tracheal lumen protein, and embryos were imaged with confocal microscopy.
50
tenuous cell projections between segments (arrow) are commonly seen. In embryos
from which the inhibitor was washed out at stage 12 (Fig. 4.3C), fewer segmental gaps
(solid arrowhead) are observed, and in general the tracheal structure is more com-
plete. These embryos frequently exhibit hyper-sprouty and long tracheal tubes (open
arrowheads). Interestingly, a supernumerary lateral trunk sometimes forms partially
or completely as demonstrated here (arrows), and the embryo is slightly larger. These
phenotypes suggest compensatory behaviors to recover tracheal distribution following
removal of SERCA inhibitor.
Embryos treated with PKC activator alone (Fig. 4.3D) always possess an intact
dorsal trunk by Btl actin-eGFP labeling. Therefore, the lack of dorsal trunk that
is seen in some embryos based on lumen protein staining likely reects a defect in
lumenization or lumen protein secretion. The tracheal structure is normal in embryos
treated with PKC activator alone based on the positions of tracheal cells. To further
investigate these defects in lumenization that may be occurring as a result of PKC
activation, w; Btl:Gal4, UAS-dsRed-NLS, UAS-actin-eGFP embryos treated with
DMSO or PMA were jointly stained with anti-GFP antibody to label all tracheal
cells and the 2A12 antibody to label lumen protein. In Figure 4.4, the rst column
of panels shows all tracheal cells by eGFP label. The second column shows 2A12
lumen protein staining, and the third column is the merged image. The top row
shows control embryos (Fig. 4.4A) with continuous lumenization of the dorsal trunk
near the top of the center image and lumenization throughout each of the smaller
branches of the developing tracheal network. The panels in row (B) show an example
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Figure 4.3: PKC activation does not perturb tracheal structure and rescues defects
from SERCA inhibition. Tracheal cells are genetically labeled by expression of the
tracheal marker Breathless (Btl) driving eGFP fused to actin. The dorsal trunk
is outlined with dotted yellow lines in each panel. (A) Control embryos treated
with DMSO. (B) Incubation with SERCA inhibitor results in breaks in the dorsal
trunk (arrowhead) and tenuous cytoplasmic connections between segments (arrow).
(C) Removal of SERCA inhibitor at stage 12 generally results in fewer gaps (solid
arrowhead) but instead an exuberance of sprouting and thickened, wavy tubules
(open arrowheads). In some cases, an extranumerary lateral trunk forms partially
or completely (arrows). (D) Treatment with the PKC activator alone gives normal
tracheal structure based on label of tracheal cells, with continuous dorsal and lateral
trunks. (E) Co-treatment with SERCA inhibitor and PKC activator fully rescues
tracheal development. Scale bar=50m throughout.
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of an embryo treated with PKC activator where half of the dorsal trunk stains for
lumen protein, but the other half does not (dotted yellow lines in center panel).
The tracheal cells are clearly present by Btl eGFP label, and yet the lumen protein
deposition abruptly stops at one of the segments of the dorsal trunk. A lumen is also
clearly visible continuing through the dorsal trunk despite the lack of 2A12 labeling
(arrowheads in merged panel). Similarly, row (C) shows an example of an embryo in
which the dorsal trunk is continuous by Btl eGFP labeling (left panel), but there is no
lumen staining throughout the entire trunk (center panel, dotted yellow lines). As in
example (B), a lumen is clearly visible throughout the trunk (arrowheads in merged
panel). Tracheal cell nuclei (yellow) are still positioned normally through these trunks
where lumen label is absent, conrming the presence of the cells (Fig. 4.5, arrows).
Thus, PKC activation does not interfere with structural formation of the tracheal
network, as evidenced by visualizing Breathless expressing cells by actin-eGFP label-
ing. Likewise, the tubes lumenize; however, there is sometimes a defect in production,
secretion, or modication of the chitinous lumenal protein identied by the 2A12
antibody.
Embryos co-incubated with both SERCA inhibitor and PKC activator (Fig. 4.3E)
display an astonishingly normal tracheal network with orderly segments and con-
nected trunks. This remarkable nding indicates that in the context of Drosophila
tracheal development, PKC activation compensates for SERCA inhibition to rescue
tracheal development. Interestingly, the lumen protein defect that is often seen in
embryos treated with PKC activator alone is less commonly observed in embryos
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treated concurrently with SERCA inhibitor and PKC activator. Rebalancing calcium
uptake and release must contribute to lumenal maturation. Yet, dual drug treatment
does not fully correct the lumen protein defect in all embryos. It is likely that calcium
feeds into the secretion or maturation of lumenal proteins.
Rescue of Drosophila tracheal development by PKC activation in the background
of SERCA inhibition diers from the case of zebrash intersomitic vascular devel-
opment, where PKC activation did not rescue. To probe whether rescue could
be achieved in another Drosophila tissue and whether it might relate to tracheal
formation being dependent solely on migration in the absence of proliferation, we in-
vestigated the eects of drug treatment on CNS longitudinal tract formation. Like the
zebrash vasculature, formation of these tracts relies primarily on axonal extension
but also involves cell proliferation.
Figure 4.6 shows images of the ventral nervecord longitudinal tracts that form
bilaterally on either side of the ventral midline in embryos from each of the drug
treatment groups. Antibody staining against Fasciclin II labels the longitudinal tracts
and motor axons. Controls treated with DMSO (Fig. 4.6A) have three parallel tracts
on each side of the midline with segmental peripheral axon projections. Treatment
with SERCA inhibitor (Fig. 4.6B) disrupts the parallel bundles and midline barrier.
The separation between dierent bundles is compromised, with merging of multiple
tracts or general disorder, as seen in g. 4.6B. Rather than axons following parallel
bundles, random projections can be seen (white arrowheads), and sometimes there
are breaks in the tracts. These mutants also often exhibit aberrant midline crossings
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Figure 4.4: Tracheal structure is normal following treatment with PKC activator, but
dorsal trunk lumen proteins are aected. Embryos were treated with DMSO (control)
or PKC activator (PMA). Tracheal cells are genetically labeled by expression of the
tracheal marker Breathless (Btl) driving eGFP fused to actin (left column, cyan),
and stained with the 2A12 antibody against lumen protein (center column, red). The
right column shows the merged images. (A) The top row depicts control embryos with
continuous lumenization of the dorsal trunk. (B and C) show embryos treated with
PKC activator where the dorsal trunk is fully continuous by Btl eGFP expression
(cyan), but lumen protein label is absent in part or all of the dorsal trunk (dotted
yellow outlines). Despite lack of lumen protein label, the trunk is visibly lumenized
(yellow arrowheads). Scale bar=50m throughout.
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Figure 4.5: The positions of tracheal cells are normal following treatment with PKC
activator, but dorsal trunk lumen proteins are aected. Embryos were treated with
DMSO (control) or PKC activator (PMA). Tracheal cells are genetically labeled by
actin-eGFP (cyan) and nuclear dsRed (yellow spots). Antibody staining with the
2A12 antibody labels lumen protein (yellow lumenal label). FasII-positive nerves
are labeled in purple. The dorsal trunk is fully continuous by Btl eGFP expression
(cyan), and where lumen protein label is absent in part of the dorsal trunk, the cell
nuclei (yellow spots) are still present and normally distributed (white arrows). Scale
bar=50m.
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and merging of the bilateral tracts at the midline (red arrowheads).
In embryos from which the SERCA inhibitor has been removed at stage 12 (Fig. 4.6C),
the CNS longitudinal tracts are vastly normalized, although sometimes the spacing
between the bundles is a bit wider than in controls. This may reect increased
expression of Robo receptors or Slit to repel axons further from the midline. During
tracheal development, removal of SERCA inhibitor resulted in an over-compensatory
sproutiness. In the case of neural development, if inhibition of SERCA can cause
abnormal midline crossings and mergings at the midline as observed, then removal of
the inhibitor may result in transient over-compensation and slight over-repulsion of
axons from the midline. This could explain the slightly wide tract spacing.
In comparison, treatment of embryos with PKA activator gives normal CNS
longitudinal tracts and FasII-positive axons (Fig. 4.6D). The axon bundles are parallel
with more or less normal spacing. In embryos treated with the combination of
SERCA inhibitor and PKC activator (Fig. 4.6E), the longitudinal tracts again are
normal. Therefore, co-activation of PKC concomitant with SERCA inhibition res-
cues Drosophila CNS nervecord development just as it rescues tracheal development.
These results indicate that the rescue of SERCA blockade by PKC operates in con-
texts that involve cell proliferation and not exclusively cell migration. The dierence
in rescue is more likely organism-dependent, perhaps with dierent PKC isoforms that
are dierentially expressed between zebrash and Drosophila. Regardless, the rescue
of SERCA blockade by PKC in both Drosophila neural and tracheal development
demonstrates that PKC-dependent SERCA regulates cell migration and can do so in
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Figure 4.6: PKC activation in the background of SERCA inhibition rescues CNS
neural development. CNS longitudinal tracts and some peripheral axons are labeled
by FasII expression in permeabilized embryos treated with or without drug. (A)
Control embryos have normal longitudinal axons and peripheral projections. (B) In
embryos treated with SERCA inhibitor, the parallel axon bundles are disarrayed and
frequently merged with random axon projections rather than parallel order (white
arrowheads). Aberrant midline crossing and merging of bilateral tracts often occurs
(red arrowheads). (C) Washout of SERCA inhibitor at stage 12 vastly normalizes
the CNS tracts, although their spacing is sometimes slightly wider than normal.
(D) Incubation with PKC activator gives normal CNS longitudinal axons. (D) Co-
incubation with SERCA inhibitor and PKC activator rescues CNS longitudinal axon
tracts. Scale bar=50m throughout.
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the context of cell proliferation. SERCA can also modulate cell proliferation, but its
dominant role appears to be regulation of cell migration (data not shown).
To quantify the severity of Drosophila tracheal and neural perturbation and res-
cue, phenotypes were categorized as normal, moderate, or severe (Fig. 4.7). To be
considered normal, an embryo had to have normal tracheal and neural structure,
as depicted in the left-hand panels (Fig. 4.7A). The embryo was classied by the
most severe phenotype it exhibited. A moderate phenotype was one with complete
tracheal or neural structure but slight disorder, exuberant sprouting, or excessively
wavy branches (Fig. 4.7B). A severe phenotype was one with overt breaks, missing
sections, fused longitudinal tracts or midline crossings, or generally severe disorder
(Fig. 4.7C).
Figure 4.8 plots the distributions of phenotype severity for each treatment group.
At least 70 embryos were counted per treatment. The embryos that were perme-
abilized and treated with DMSO (control) are mostly normal (89%). Inhibition of
SERCA results in a severe phenotype in 86% of embryos, with only a few percent
that look normal. Washout of SERCA inhibitor at stage 12 signicantly normalizes
tracheal and neural development, with 28% being normal, 36% having a moderate
phenotype, and 36% severe. Co-incubation with PKC activator and SERCA in-
hibitor gives 68% of embryos with normal nerves and trachea, 25% with a moderate
phenotype, and just 7% with a severe phenotype. A p value of less than 0.001 by
Chi-square analysis distinguishes the washout and CPA+PMA rescue from the CPA-
treated embryos, with PKC activation coincident with SERCA inhibition producing
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Figure 4.7: Classication of Drosophila tracheal and neural phenotypes. Embryos
were categorized by the most severe phenotype they exhibited. (A) Embryos with
normal tracheal and neural structure as depicted were classied as normal. (B) A
moderate phenotype was one in which the trachea had exuberant sprouting, wavy
tubes, or slight disorder, or the neural longitudinal bundles were slightly disordered.
(C) A severe phenotype was one with overt breaks in the trachea or longitudinal
fascicles, severe disorder and missing segments, or merged tracts and aberrant midline
crossings. Scale bar=50m throughout.
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the most substantial rescue. For additional examples of the phenotypes observed, see
Figs. B.1 and B.2.
Inhibition of the SERCA pump is expected to operate cell-autonomously whereby
the functions of cells that take up the inhibitor would be perturbed. However,
perturbations of individual cells can have an eect on neighboring cells. To assess
whether defects in FasII-positive neurons or the trachea aected the other or if the
perturbations were mostly occurring independently of the other in each cell type,
Btl eGFP tracheal cells and FasII-positive cells were stained in llet preparations.
Figure 4.9A shows an example where SERCA inhibition resulted in breaks in the
dorsal tracheal trunk. Arrows in the top panel indicate a gap and a section with a
thin connection between trunk segments. The middle panel shows that the nerves
are normal, and it is apparent in the merged image that the peripheral neural axons
still properly project to the segments with disrupted trachea. Similarly, Figure 4.9B
shows an example where the tracheal structure is normal but there is a midline
crossing of the longitudinal fascicles (arrow in middle panel). The tracheal cells
are still properly located along the longitudinal tracts (merge). These results are
consistent with the tracheal and neural disruptions arising in a cell-autonomous
manner in cells aected by the inhibitor. Nevertheless, in severe cases it is still likely
that disruptions of one cell type cause perturbations of nearby interacting tissues.
Targeted disruption in specic cell types and analysis of many dierent tissues would
be required to denitively assess how disruptions in SERCA activity in one cell type
aect neighboring tissues.
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Figure 4.8: Quantication of Drosophila tracheal and neural phenotypes demonstrates
the most signicant rescue by SERCA inhibition by PKC activation. Embryos were
categorized by the most severe phenotype they exhibited. In controls that were
permeabilized and treated with DMSO, 89% of embryos have both normal trachea and
nerves and 5.6% have a severe disruption. In contrast, 86% of embryos treated with
SERCA inhibitor display a severe neural or tracheal phenotype, with only 2.6% being
normal. Washout of SERCA inhibitor at stage 12 normalizes 28% of embryos, leaving
36% with a moderate phenotype and 36% with a severe phenotype. Co-treatment
with PKC activator and SERCA inhibitor results in 68% of embryos having normal
trachea and nerves, 25% with a moderate phenotype, and only 7% with a severe
phenotype. The washout and dual drug treatment rescue are statistically signicant
to less than 0.001 by Chi-square analysis, with PKC activator in the background of
SERCA inhibition producing the most substantial recovery.
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Figure 4.9: Perturbations in trachea and nerves arise independently. Tracheal cells
and FasII-positive nerves were labeled to determine whether tracheal and neural
defects coincided or tended to occur independently. The top panel depicts Btl eGFP
tracheal cells in llet preparations; the middle panel shows FasII-positive nerves,
and the bottom is the merged image. (A) shows an example of an embryo with
gaps in the dorsal tracheal trunk (arrows) but normal nerve structure and segmental
axon projections despite the tracheal breaks (merge). (B) shows an example of an
embryo with normal tracheal structure but a midline crossing of longitudinal fascicles
(arrow). The tracheal cells are still properly located along the nerve tracts (merge).
Scale bars=50m.
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4.1 Summary
Treatment of Drosophila embryos with SERCA inhibitor demonstrates that blockade
of SERCA activity disrupts tracheal and neural development. Formation of the
tracheal system occurs entirely by cell migration following the complete cessation
of cell proliferation, and inhibition of SERCA disrupts the proper patterning of the
trachea, resulting in segmental gaps, broken trunks, or severe fragmentation of tubes.
Likewise, SERCA inhibition during neural development manifests with breaks in the
longitudinal connectives, improper tract mergings, and structural disorder indicative
of perturbed pathnding or migration. These tracheal and neural eects are ame-
liorated upon removal of inhibitor, although defects persist. Inhibitor washout also
frequently results in a phenotype of exuberant sprouting of tracheal tips and elongated
tubes. In contrast, simultaneous treatment of embryos with SERCA inhibitor and
PKC activator substantially rescues tracheal and neural development. Based on
these results, dynamic analysis of cell migration during non-proliferative tracheal
development is necessary to conrm that migratory defects account for the observed
phenotypes.
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Chapter 5
SERCA inhibition disrupts cell
migration
Results from inhibition of the SERCA pump in zebrash vascular growth andDrosophila
tracheal and neural development implicate SERCA in regulating cell migration. Dy-
namic imaging and analysis of embryonic Drosophila tracheal development was used
to ascertain whether disrupted cell migration explains the phenotypes observed with
SERCA blockade. This system excludes any contributing eects on cell proliferation
since the embryonic tracheal network assembles in the absence of cell division.
Transgenic w; Btl:Gal4, UAS-dsRed-NLS, UAS-actinGFP ies label all tracheal
cells with GFP-tagged actin and nuclear dsRed uorophore. Therefore, the cytoskele-
ton and nuclei of the cells can be spectrally distinguished and followed over time.
Three embryos per group were treated with DMSO (control) or SERCA inhibitor
(CPA) and dynamically imaged with confocal microscopy. Every 3 to 3.5 minutes,
a stack of images was collected to follow tracheal development on one side of the
embryo. Individual lateral trunk cells were tracked based on the positions of their
nuclei from approximately stage 14 to early stage 16, during which time the lateral
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trunk should fuse across adjacent segments.
Figure 5.1 shows three timepoints during lateral trunk development in control
embryos that were permeabilized and treated with DMSO. Figure 5.1A shows the
embryo at the beginning of this time period, and the white dots mark the nuclei of
opposing cells in neighboring segments that must meet to form a continuous trunk.
Panel B depicts the embryo 35 minutes later. The cells in neighboring segments have
migrated towards each other. The dragon tails on each spot indicate each cell's path
over the previous 10 timepoints, and they show how the pairs of cells are moving
towards each other. In Figure 5.1C, the neighboring cells are closer together still, and
the lateral trunk is becoming a continuous structure.
In comparison, an embryo that was permeabilized and treated with SERCA
inhibitor and imaged over the same period of development is shown in Figure 5.2.
Cells were tracked on both sides of aected segments where lateral trunk fusion fails
to occur. Over the timecourse from Figure 5.2A through C, the cells in opposing
segments move more or less parallel to each other, being carried along with the
outward expansion of the tissue as the embryo develops. Unlike in the control, the cells
do not converge with their neighbors, and the lateral trunk remains discontinuous.
A gap in the dorsal trunk also persists even as the rest of the trunk lumenizes,
indicating that those cells are likewise aected by the inhibitor. Some of the lateral
trunk segments do, fuse, however. This is consistent with SERCA acting in a cell-
autonomous manner to direct individual cell behaviors.
The paths of migration and overall displacement of the tracked lateral trunk cells
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Figure 5.1: Caption next page.
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Figure 5.1: In control embryos, tracheal cells in adjacent segments migrate towards
each other to form the lateral trunk. Live Drosophila embryos with uorescently
labeled tracheal cells were imaged with confocal microscopy to trace cell movements
over time in controls treated with DMSO. (A) shows the embryo at stage 14 when
the lateral trunk is beginning to form. White spots mark the positions of cell nuclei
over time in adjacent segments that fuse to form the continuous trunk. The lower
panels show timepoints 35 minutes (B) and 70 minutes (C) later as the trunk is fusing.
Dragon tails on the spots depict the cells' movements over the previous 10 timepoints.
Over the timecourse, the opposing cells in the lateral trunk of adjacent segments
move closer together, and a continuous lateral trunk forms. Scale bars=20m. Actin
cytoskeleton is cyan and nuclei are magenta.
in the control and SERCA-inhibited embryo are compared in Figure 5.3. In each case,
the squiggly path traces the migration route of the tracked cell nucleus. The path
progresses from yellow to orange to red over the timecourse. White arrows indicate
the overall displacement of each cell nucleus. It is clear by the converging pairs of
displacement arrows that in the control (Fig. 5.3A), lateral trunk cells from adjacent
segments move towards each other and meet. They fuse to form an uninterrupted
lateral trunk. This is contrary to two of the segments of the SERCA-inhibited embryo
(B), where the displacement arrows for cells in opposing segments are more or less
parallel to each other. These cells are passively moving with tissue expansion but are
not substantially narrowing the distances between them. The result is discontinuities
in the lateral trunk between these aected segments. A break in the dorsal trunk is
also evident, despite lumenization of the trunk on either side. These breaks persist
through the remainder of the embryo's development. At the same time, cells from
some of the segments do converge to form a fused lateral trunk between them. It
is likely that SERCA is not suciently inhibited in these individual cells to disrupt
their migration.
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Figure 5.2: Caption next page.
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Figure 5.2: When SERCA is inhibited, tracheal cells destined to form the lateral trunk
do not converge, leaving discontinuities. Live transgenic Drosophila embryos were
treated with SERCA inhibitor, and tracheal development was imaged dynamically
with confocal microscopy. (A) depicts the tracheal structure at approximately stage
14. White spots mark the nuclei of cells on opposing sections of trachea that should
converge to form the lateral trunk. Dragon tails in (B) and (C) trace the path of the
cells over the prior 10 timepoints. The panels at 35 minutes (B) and 70 minutes (C)
demonstrate that these cells move more or less parallel to each other with overall tissue
expansion, rather than converging. Some segments do connect, whereas the cells that
are suciently aected by SERCA inhibition fail to migrate. Scale bars=20m. Actin
cytoskeleton is cyan and nuclei are magenta.
To quantify the migration defect in embryos treated with SERCA inhibitor, the
relative convergence of neighboring cells in adjacent segments was determined. The
three-dimensional position of each tracked cell at the start and end of the time
period were exported to MATLAB, and the angle of convergence or divergence formed
by the displacement vectors for each pair of cells was calculated. Throughout this
time, passive movement from overall embryo development is pushing tracheal cells in
dierent directions and by dierent amounts at dierent positions in the tracheal tree.
It is therefore dicult to remove this passive motion without inadvertently altering
the movement that is attributed to cells as active migration. Simply measuring speed
of overall movement is also not informative because of this passive motion. For this
reason, we calculated the migration of one cell relative to its partner to negate any
contribution from passive motion.
Figure 5.4A plots the vectors of directional movement of one cell in each pair
relative to its partner. Arrows pointing to the right indicate the angle of convergence
of the pair of cells, while arrows pointing left indicate the angle of divergence. The
vertical line references parallel movement. Red arrows represent the relative migration
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Figure 5.3: Tracking individual cells through a dynamic timeseries shows that cells
migrate convergently to form a trunk in controls but drift in parallel when SERCA is
inhibited, leaving structural gaps. Overall migration paths and total displacements of
tracheal cells tracked during the formation of the lateral trunk are shown for DMSO-
treated controls (A) and embryos treated with SERCA inhibitor (B). The yellow-
to-red traces map the positions of the individual cell nuclei during the timecourse.
In controls (A), the cell displacement arrows illustrate the convergence of cells from
adjacent segments to form the continuous lateral trunk. In contrast, with SERCA
inhibition (B), the displacements of cells in neighboring segments are approximately
in parallel directions, and the lateral trunk remains broken through the remainder of
the embryo's development. Scale bars=20m. Actin cytoskeleton is cyan and nuclei
are magenta.
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of pairs of cells from embryos treated with SERCA inhibitor, and black arrows repre-
sent pairs of cells from DMSO-treated control embryos. The thick arrows represent
the median for each treatment group. Pairs of cells from control embryos converge
at a median angle of 31 degrees. This convergence is expected as the cells from
adjacent segments must move together in order to form a continuous lateral trunk.
In contrast, pairs of cells from aected segments of SERCA-inhibited embryos do not
migrate towards each other, but instead have a median divergence of 9 degrees.
The dierence in migratory behavior between control and SERCA-inhibited em-
bryos is also apparent by calculating the actual amount that cells from adjacent
segments move closer together. Pairs of cells from control embryos reduce the starting
separation between them by an average of 58% during the measured time period,
while cells from embryos treated with SERCA inhibitor on average increase their
separation by 5% (Fig. 5.4B). Thus, individual cells fail to migrate properly when the
SERCA pump is blocked, and this results in the breaks in the tracheal network that
characterize these mutants.
To gain more insight into specic migratory behaviors that are aected in cells
with suciently inhibited SERCA, we looked more closely at tracheal cells on either
side of a gap in the dorsal trunk. Cell migration entails active protrusion of the
cytoskeleton, and this might be absent in cells aected by SERCA inhibitor. The
panels in gure 5.5 show snapshots from consecutive timepoints every 3.5 minutes
in a timeseries of a live embryo treated with SERCA inhibitor. A gap in the dorsal
trunk is evident (Fig. 5.5A, space occupied by white arrow). The cell on the right side
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Figure 5.4: Cells in neighboring segments that form the lateral tracheal trunk actively
migrate towards each other in control embryos but fail to migrate when aected by
SERCA inhibitor. The displacement vector for each tracked cell was determined
from the positions of cell nuclei at stage 14 before lateral trunk formation and at
the end of the time period of study. (A) The angle of convergence or divergence
was calculated for each pair of cells that should join to form the lateral trunk. The
vectors of directional movement of one cell in each pair relative to its partner are
plotted for controls (black) and SERCA-inhibited embryos (red). In controls, pairs of
cells converge between neighboring segments, at a median angle of 31 degrees, while
pairs of cells in CPA-treated embryos do not move towards each other, but rather
diverge at a median angle of 9 degrees. (B) The start and end separation between the
pairs of cells was calculated for each treatment group. In controls, cells in adjacent
segments of the lateral trunk reduce the separation between them by 58% on average,
while in SERCA-inhibited embryos, the separation increases by 5% on average.
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of the gap is extending a cytoskeletal projection that is visible by actin labeling in
cyan (white arrow). On the contrary, the opposing cell on the other side of the gap is
not reciprocating (red arrow). Through the timecourse, the cell on the right appears
to actively search the space for a partner as it extends the cytoskeletal projection
(Fig. 5.5A-L). However, the opposing cell does not participate, and through the end
of embryonic development of this embryo, the gap in the trunk persists.
Interestingly, cells within the dorsal branch of these segments (Fig. 5.5A, yellow
arrow) interact with each other. A cell in the left branch which is not at the tip
responds to the tip cell of the branch on the right and extends towards it (Fig. 5.5F,
yellow arrow). In panel G they fuse with each other. These branches would normally
fuse with dorsal branches extending from the contralateral side of the embryo, and
the tip cell on the left branch seems to still be searching for a contralateral partner
(Fig. 5.5J,L, green arrows). The gap in the dorsal trunk between these ipsilateral
segments may somehow be leading them to fuse with each other as well. Perhaps this
helps to balance tension from lumenal uid pressure or some other property of the
tubes. Both of the cells from these dorsal branches appear to be actively engaged in
the interaction to create this fusion, while in the dorsal trunk, the cell on one side is
not participating to close the gap. The defect in extending cytoskeletal projections is
likely analogous to the branching defect observed in zebrash endothelial cells, where
fewer cytoplasmic projections were seen.
To denitively know whether SERCA is inhibited in both of these cells on either
side of the gap or just in the quiescent cell on the left, and what the calcium
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Figure 5.5: Active cytoskeletal dynamics are lacking where gaps remain in the tracheal
network. The panels are from consecutive timepoints every 3.5 minutes from a
timelapse of tracheal cells in an embryo treated with SERCA inhibitor. (A) At a gap
in the dorsal trunk, the cell on the right extends a cytoplasmic projection towards the
adjacent segment (white arrow), but the partner in that segment does not respond
(red arrow). (A-L) Through the timecourse, the cell on the right continues to search,
but the cell on the left does not reciprocate, and the gap persists. The yellow arrow
in (A) points to cells in neighboring dorsal branches that extend projections towards
each other (F, yellow arrow), and in (G) they fuse. These branches normally fuse
with contralateral dorsal branches. (J,L) The left dorsal branch tip cell may still be
extending towards a contralateral partner (green arrows). Scale bar=20m.
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signature is that instructs cells to migrate, it is necessary to look at the actual
calcium dynamics of individual cells. The interplay between IP3-mediated release
of calcium from the ER and calcium sequestration by the SERCA pump could be
establishing an oscillating dynamic of calcium within the cell, or periodic spikes,
or steady state calcium levels. Specic patterns of calcium activity could drive
cytoskeletal rearrangements or other behaviors for cell motility. The GCamp3 calcium
indicator permits visualization of dynamic calcium activity because it uoresces upon
binding to calcium, so the intensity of uorescence can be used to quantify the relative
amount of calcium present in the cell cytoplasm.
Drosophila embryos with Btl driving expression of GCamp3 only in tracheal cells
(Btl-Gal4, UAS-GCamp3/CyO) were imaged with 2-photon light sheet microscopy
to analyze the dynamics of calcium in individual cells during tracheal development.
With light sheet microscopy, or selective plane illumination microscopy (SPIM), a
thin sheet of light is generated to illuminate an entire plane of the sample rather than
raster scanning a point focus across the two-dimensional plane. The entire plane is
imaged simultaneously with a camera. Only the plane of focus is illuminated, so
there is no out-of-focus uorescence that must be excluded. The technique aords
a time resolution on the order of milliseconds to capture an image, which is about
30 times faster than using conventional confocal microscopy. The time resolution of
the light sheet microscope is sucient to capture changes in calcium dynamics, and
preliminary imaging demonstrates a calcium spiking behavior in tracheal epithelial
cells (Fig. 5.6A-C). Dramatic calcium spikes are observed throughout the tracheal
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system in embryos at stage 15 to 16, and they propagate through adjacent cells as
the cells become electrically coupled. At stages 15 to 16, the individual spikes last on
average 20-30 seconds within an individual cell and exhibit a denitive spike shape
(Fig. 5.6D).
Preliminary analysis of the calcium dynamics of individual cells in controls reveals
an oscillatory pattern of calcium activity in cells of the lateral trunk which are
migrating to form a continuous trunk (Fig. 5.6E, arrows). Figure 5.6F depicts the
intensity prole over time for one of these cells, which shows oscillations in calcium
levels by GCamp3 uorescence. In embryos treated with SERCA inhibitor, these
oscillations are absent (Fig. 5.6G, H). Further analysis of controls, SERCA-inhibited
embryos, and embryos treated with the combination of SERCA inhibitor and PKC
activator should clarify the precise calcium activity that drives cell migration and
that is absent in SERCA-inhibited embryos.
5.1 Summary
In summary, dynamic imaging of embryonic Drosophila tracheal development demon-
strates that the migration of cells is indeed aected in embryos treated with SERCA
inhibitor. This migration problem accounts for the observed defects in tracheal
development. Each defect is a manifestation of individual cells being aected by
the drug and failing to migrate, leaving gaps in the tracheal network. A failure to
mobilize the cytoskeleton and extend cytoskeletal projections may characterize these
cells. Dynamic imaging of the calcium dynamics of individual cells reveals dramatic
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Figure 5.6: Tracheal cells exhibit an active calcium spiking behavior. (A{C) Z-
stack projections at individual timepoints of control embryos expressing GCamp3
in tracheal cells reveal calcium spikes that propagate through electrically coupled
cells. Dierent cells are spiking in each image, demonstrating activity across the
tracheal network. (D) An example intensity prole of a spiking cell with 20ms time
resolution shows the typical shape and duration of these spikes, which on average last
20-30 seconds. (E,G) Zoomed-in views of Z-stack projections of the cells destined
to form the lateral trunk in control (E) and SERCA-inhibited (G) embryos show
calcium activity in the migrating control cells (E, arrows) that is absent in the non-
migratory cells of the CPA-treated embryo (G) that fail to form the lateral trunk.
(F,H) Intensity proles of these cells reveal calcium oscillations in the control cells
but not in the SERCA-inhibited cells. Scale bars in A|C=50m. Scale bar for E,
G=10m.
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calcium spiking activity and should elucidate the precise signature of calcium activity
that directs cell motility in normal cells based on a lack of that dynamic in cells that
fail to migrate.
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Chapter 6
Conclusions and discussion
Inhibition of the SERCA pump during zebrash vascular development and Drosophila
tracheal and neural development impedes proper outgrowth and structural formation
consistent with defects in cell migration. Zebrash intersomitic vessels remain shorter
and less branched; Drosophila trachea and nerves exhibit breaks, aberrant fusions, and
disorder. These phenotypes could result from disruption of various cell behaviors, such
as cell migration, shape change, or cell adhesion. The Drosophila tracheal network
forms in the absence of proliferation and as such is a useful system for dissecting the
role of SERCA activity for cell migration without contributions from proliferation.
6.1 Tracheal structural determinants
Tracheal tube shape is determined by genetic specication as well as cell polarization
and lumenization. Signaling molecules encoded by decapentaplegic (DPP) and epi-
dermal growth factor (EGF) and their downstream transcription factors, knirps and
spalt, respectively, are important for specifying tracheal branch identity and migration
(Aolter et al., 1994; Beitel and Krasnow , 2000; Chen et al., 1998; Vincent et al.,
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1997; Wappner et al., 1997; Ruberte et al., 1995). The breaks in tracheal structure
observed with SERCA inhibition are reminiscent of some of the phenotypes seen
when knirps and spalt signaling are altered (Chen et al., 1998). In that study, proper
positional migration of cells was perturbed by deleting or misexpressing these genes,
so cells would not migrate to their proper destination and would thus fail to form
specic segments of the tracheal network. Depending on the combination of over- or
under-expression of genes, specic tracheal tubes were aected. Following inhibition
of SERCA activity, we observed similar breaks in segments; however, inhibition of
SERCA caused disruption of dierent segments in dierent embryos, collectively
aecting all parts of the tracheal tree. Therefore, while the genetic perturbation
studies specically misdirected particular tracheal cells, SERCA inhibition broadly
perturbed tracheal morphogenesis. This suggests that SERCA inhibition aected
the migration of cells possessing sucient levels of inhibitor, and the phenotype that
resulted depended on which cells were inhibited.
The necessity for SERCA activity for proper cell migration is consistent with
the results of the zebrash intersomitic vasculature development, and it explains
how inhibiting SERCA in the Drosophila tracheal system can produce such severe
deformities. The similarity of phenotypes that result from SERCA inhibition and
some of the knirps and spalt mutations also suggest that DPP and EGF signaling
through knirps and spalt may eventually act through calcium activity to direct cell
migration. It would be interesting to see if modulation of SERCA and PKC activity
aected the phenotypes observed following ectopic knirps or spalt expression.
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6.2 Lumenization and tube shape
Individual cell shape was not dierent between control and SERCA-inhibitedDrosophila
embryos, but tube length and lumen alterations were observed following inhibitor
washout and PKC activation, respectively. Tracheal tube size is controlled by various
chitinous proteins which are secreted into the tracheal lumen at dierent stages of
tracheal development (Beitel and Krasnow , 2000). These proteins play an important
role in directing the nal shape and dimensions of the tracheal tubes. At early
stages, the proteins serve to induce lumenal widening (Devine et al., 2005; Wang
et al., 2006), but at later stages, the proteins signal to cells to stabilize the lumen at
a certain size and prevent over-dilation or lengthening (Araujo et al., 2005; Swanson
et al., 2009). Maturation of the lumen proteins through these dierent stages requires
modications of the lumen contents by two secreted deacetylases, Vermiform and
Serpentine (Luschnig et al., 2006; Nelson et al., 2010; Schottenfeld et al., 2010). These
modications are highly dependent on proper cell polarization. Apical secretion of
Verm and Serp into the lumen requires intact adherens junction and septate (tight)
junctions (Wang et al., 2006), which also organize basolateral polarity complexes.
Mutations in the septate junction disrupt lumenal secretion (Llimargas et al., 2004;
Nelson et al., 2010; Swanson et al., 2009). Thus, perturbing septate junctions blocks
lumenal maturation, and the tubes elongate excessively and form cysts or constric-
tions (Llimargas et al., 2004).
Following washout of SERCA inhibitor from Drosophila embryos at stage 12, the
resulting tracheal tubes were often excessively elongated and convoluted (Fig. 4.2C
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and B.1C). The elongated nature of these tubes could be a result of lumen protein
defects that have been reported to result in long tubes. However, 2A12 staining in
these embryos was not perturbed, and the tube widening and constrictions described
in conjunction with the tube length mutants are not observed with SERCA blockade.
Thus, the fragmentation and segment breakages are likely a result of defects in a
dierent process.
6.3 Feedback regulation
The elongated tubes and hyper-sprouty phenotype following removal of SERCA in-
hibitor could simply be an over-correction to the inhibited state. If cell migration was
blocked by the drug, the cells may be trying to 'catch up' to where they should be
and in the process extend excessive cytoplasmic projections and over-stretch, forming
convoluted tubes. Alternatively, there may be a negative feedback mechanism depen-
dent on SERCA activity that constrains the SERCA-dependent migratory activity of
cells. This could be analogous to activator-inhibitor feedback in seashell patterning or
FGF signaling that promotes tracheal and lung branching but activates an inhibitor,
sprouty, which restrains the branching activity by modulating downstream FGF
signaling (Meinhardt , 2009;Mailleux et al., 2001). Upon removal of SERCA inhibitor,
cell migration could be rapidly activated, but the feedback to constrain it would have
a slight delay in turning on, enabling the migratory activity to get ahead of itself.
This could explain the hyper-sprouty and wavy tubes often observed after washout
of SERCA inhibitor.
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Interestingly, in a few cases, an extra partial or complete lateral trunk formed
after washout of SERCA inhibitor (Fig. 4.3C). This astounding phenotype was much
less common than the phenotype with normal structure but sprouty, convoluted
branches. Yet it indicates that there may be exibility in tracheal network structuring
or branch specication. One possibility is that the formation of the tracheal trunks
involves activators and inhibitors that lay out a global pattern like in seashell stripes.
Alternatively, a particular calcium dynamic may specify the lateral trunk fate. If
this dynamic is achieved in more cells than normal following washout of the SERCA
inhibitor, it is possible that it instructs the cells to form more than one lateral trunk.
The calcium-mediated signal could, however, occur over an expanded time window
rather than a spatial window, instructing a rst batch of cells to form the lateral
trunk as normal, and then if it persisted or occurred again, it might instruct a second
batch of cells to form a second lateral trunk. Analysis of the calcium behavior of
individual cells during tracheal development might reveal such a signature calcium
dynamic that instructs lateral trunk formation.
In comparison, embryos treated with PKC activator alone commonly display a
phenotype of lack of label of the 2A12 lumen protein antigen in the dorsal trunk, but
normal tracheal network structure and lumen dimensions. These ndings suggest that
ectopic PKC activation alters lumen protein maturation such that the 2A12 antigen
is reduced or absent. But there must be lumen protein present and sucient redun-
dancy in the function of the dierent proteins to achieve proper lumenization and
homogeneous widening. Cell junctions and apical secretion must not be perturbed,
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otherwise dilations and constrictions as seen in the septate junction mutants would be
expected. Likewise, cell migration and positional information remains normal as the
tracheal cells are present and the network structure is normal in these embryos. The
actin cytoskeletal network is also not aected (based on actin-eGFP localization), so
vesicle transport is unlikely to be the cause of the 2A12 perturbation (Massarwa et al.,
2009). Since cell polarity, cytoskeletal, and secretion problems are not apparent, the
defect may be limited to localization of the particular lumen protein recognized by
the 2A12 antibody.
6.4 Neural guidance
The longitudinal nerve tracts of the CNS form primarily by patterned axonal exten-
sion but do involve cell proliferation, and again in this system, SERCA inhibition
produces a range of breaks, tract mergings, aberrant midline crossings, and general
disorder (see Fig. B.2). Migration of glial cells, primary neurons, or follower axons
could be aected, and the merging of tracts seen at the level of A4|A5 (Fig. 4.6B,
center red arrow) may also reect perturbed cell migration during germ band retrac-
tion, as migration problems often manifest in these segments. Pioneer axons depend
on a combination of guidance cues from glia, interneurons, and each other to form
the longitudinal fascicles (Hidalgo and Booth, 2000; Kuzina et al., 2011; Learte and
Hidalgo, 2007; Raper and Mason, 2010). The glial cells are not stationary; they
migrate along with and ahead of some of the pioneer axon growth cones and appear
to attract the axons, which extend more slowly in the absence of glia (Hidalgo and
85
Booth, 2000; Parker and Auld , 2004).
Rearrangement of the rst fascicle by defasciculation and refasciculation to ulti-
mately form three fascicles on each side of the midline depends on the presence of
glial cells. The fusion of fascicles sometimes seen following SERCA inhibition could
be a result of SERCA blockade aecting glial cell migration and, in turn, pioneer
axon pathnding. Rather than organizing into three bundles, they may remain as a
single tract in sections. Misexpression of adhesion proteins, such as FasII, could also
aect the alignment of fascicles and result in improper joining of dierent pathways
(Goodman, 1996).
Abnormal midline crossing could also reect changes in expression of repulsion
signals or receptors, or midline glial cell behaviors (Ratnaparkhi and Zinn, 2007).
Aecting the migration of the midline glia could mis-guide commissural axons. How-
ever, it is also possible that axon guidance itself is perturbed by SERCA inhibition
with neurons failing to migrate properly despite the presence of proper guideposts
and signals. Furthermore, as axons-axon interactions are important for primary and
follower axon pathnding, disruption of these interactions could explain some of the
neural phenotypes observed (Imai and Sakano, 2011). It would be interesting to
determine whether Eph or Ephrin receptor expression is perturbed in these mutants,
as this would aect axon sorting and guidance interactions (Imondi et al., 2000; Reber
et al., 2004).
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6.5 PKC activation
Co-treatment of Drosophila embryos with SERCA inhibitor and PKC activator res-
cues tracheal and neural development. This suggests that balancing the reduced
SERCA activity with reduced IP3-mediated calcium release from the ER can com-
pensate for reduced calcium sequestration, and cell migration can proceed suciently
normally to generate the typical neural and tracheal networks. While PKC activation
rescues in Drosophila, in zebrash intersomitic vessels, PKC activation in the back-
ground of SERCA inhibition produced results similar to those of SERCA inhibition
alone, with a sometimes more severe eect. This dierence may be specic to tissue
type, although PKC activation also rescued Drosophila neural development. Species-
specic dierences likely contribute, with dierent expression of various PKC isoforms
that are variably involved in regulating dierent cell behaviors through distinct down-
stream targets.
In zebrash vascular development, PLC1 acts downstream of the VEGFR2 ho-
molog, kdrl and is important for endothelial dierentiation and morphogenesis (Law-
son et al., 2003). PLC1 activity is required cell-autonomously in endothelial cells to
migrate from the dorsal aorta and posterior cardinal vein and form the intersomitic
vessels (Covassin et al., 2009). PLC1 knockout embryos do not form intersomitic
vessels. Activation of PLC1 can lead to MAPK or Akt signaling, but activation
of these pathways does not rescue intersomitic vascular development, meaning these
are not the downstream eector pathways. This is consistent with our ndings that
regulation of calcium activity is the important readout of this pathway and that it
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modulates cell migration.
Therefore, in the context of zebrash intersomitic vessel development, both pro-
longed or elevated calcium exposure, which is expected by SERCA inhibition, and
insucient production of IP3 following PKC activation are likely to disrupt cell
motility. This is consistent with our ndings that concomitant inhibition of SERCA
and activation of PKC can result in an additive detrimental eect on intersomitic
vessel outgrowth.
On the contrary, PKC activation has previously been reported to rescue calcium
currents in Drosophila (Gu and Singh, 1997). In larval skeletal muscle, a muta-
tion in PLC, norpA, decreases muscle calcium transients through the membrane
dihydropyridine (DHP)-sensitive calcium channel, and activation of PKC rescues the
current. The DHP-sensitive calcium channel is dierent from the IP3R channel on the
endoplasmic reticulum that responds to IP3 for calcium release, but similar regulatory
mechanisms may be at play. It is possible that PKC is directly phosphorylating the
channels. However, in the case of the skeletal muscle rescue, the eect is to increase
calcium transient, whereas in the trachea and nerves, rescue is presumably achieved by
reducing calcium release to balance the SERCA inhibition. It is still unclear exactly
how PKC is mediating rescue of calcium dynamics in both of these cases. Analysis
of the actual calcium activity in tracheal cells under the inuence of SERCA and
PKC modulators will hopefully shed light on the regulatory pathway. Regardless, the
dierent combination of activities and isoforms of proteins involved in the calcium
release from the endoplasmic reticulum likely contribute to the dierence in PKC-
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mediated eects in zebrash vasculature versus Drosophila trachea and nerves.
6.6 Conserved regulation of migration and branch-
ing
Dynamic analysis of the tracheal development reveals that SERCA-dependent defects
in cell migration indeed account for disrupted tracheal development, and likely serves
the same role in neural and endothelial migration and branching. Individual cells
fail to migrate to their destined locations and interact with partner cells in adjacent
segments, and the result is the persistence of breaks between segments that should
be connected. The migration defect is consistent with a requirement for SERCA
activity to modulate calcium levels and direct individual cell movement, and this is
applicable across species and tissue types. The extent of the phenotype correlates
with the location and number of cells that are suciently aected by the SERCA
inhibitor. Similarly, budding activity by extending cytoskeletal projections is aected
in both zebrash and Drosophila. Thus, SERCA serves as a general regulator of
cell migration and branching across species, tissues, and developmental programs.
Modulation of calcium dynamics to encode a branching program is a conserved,
generalizable mechanism that obviates the need for specic morphogenetic signals
to direct branch formation in each developmental system.
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Part II
Lung branching takes nerve
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Chapter 7
Nerves are required for branching
morphogenesis in mammalian lung
and Drosophila trachea
7.1 Introduction
The lungs develop as a bud from the foregut that forms in the fourth week of
human gestation and at embryonic day 9.5 (E9.5) in the mouse (Costa et al., 2001;
Warburton et al., 2000, 2005). Numerous morphogens, including broblast growth
factors (FGFs) from the heart and bone morphogenic proteins (BMPs) and retinoic
acid (RA) produced in the foregut endoderm and mesenchyme are necessary to
pattern the anterior-posterior fates of the foregut endoderm (Chen et al., 2010; Tiso
et al., 2002; Cardoso and Lu, 2006; Serls et al., 2005; Warburton et al., 1998). Wnt
and RA signaling in the mesenchyme around the ventral foregut are involved in
inducing Nkx2.1 and sonic hedgehog (Shh) in the ventral foregut, which are necessary
for lung bud specication (Desai et al., 2004; Harris-Johnson et al., 2009; Goss et al.,
2009). Sox2 expression in dorsal foregut limits lung induction to the ventral region
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(Que et al., 2007). Loss of Nkx2.1 results in formation of only rudimentary lung buds
and failed separation from the esophagus (Litingtung et al., 1998; Minoo et al., 1999;
Jacobs et al., 2012). Shh is also necessary for separation of the lungs and trachea
from the foregut and for epithelial branching, but the epithelial cells that are present
can dierentiate (Pepicelli et al., 1998).
RA integrates Wnt and Tbx4 signaling in the mesenchyme to induce mesenchymal
expression of Fgf10 (Chen et al., 2010), which is restricted by Shh to the mesenchyme
surrounding the growing tips of lung buds (Morrisey and Hogan, 2010; Pepicelli et al.,
1998). Tgf from the trachea and proximal bronchi inhibits Fgf10 expression there
to conne branching to distal regions (Serra et al., 1994; Zhao et al., 1996; Pelton
et al., 1991). This localized Fgf10 expression is necessary for epithelial bud outgrowth
to form the iterative branched structure of the lung. The pattern of branches that
generate the mammalian lung is highly stereotyped, with the sequence of branches
that form being nearly identical from one individual to the next (Metzger et al.,
2008). The basic pattern of branches is rst laid out, and then at later stages in lung
development, cells dierentiate into specic subtypes to form alveoli and provide the
secretory, absorptive, and gas exchange functions of the lungs (Morrisey and Hogan,
2010).
Fgf10 acts on FGF receptor (Fgfr) 2b in the adjacent bronchial epithelium to
induce bud outgrowth (Bellusci et al., 1997; Min et al., 1998). Excess Fgf10 increases
lung branching. Conversely, over-expression of Shh suppresses Fgf10, and branching
is reduced. Fgfr signaling in turn upregulates Sprouty2 (spry2) in the epithelium.
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Spry2 limits downstream MAPK signaling to restrain branch outgrowth except right
at the tip of the growing bud (Mailleux et al., 2001; Tet et al., 2002).
Depletion of endothelial cells from lungs in vivo using an inducible VEGF decoy
receptor results in a reduction of branching overall, and particular inhibition of
orthogonal branches that make the lungs thicker (Lazarus et al., 2011). However,
the epithelium continues to proliferate, generating more cystic, dilated airways. To
the contrary, exogenous Vegf164 (an isoform of Vegf-A) promotes mesenchymal pro-
liferation and epithelial branching, likely by indirectly stimulating growth-promoting
factors in the mesenchyme (Moral et al., 2006). Furthermore, endothelial cells and the
epithelium interact through Shh signaling, as vasculature is reduced in Shh knock-outs
(Pepicelli et al., 1998), and Shh signaling is perturbed following vascular depletion,
resulting in diuse mesenchymal Fgf10 expression (Lazarus et al., 2011). Thus,
endothelial cells also play a role in directing stereotyped lung branching.
Various basement membrane proteins are expressed throughout the lung and play
a role in branch formation. At branch tips, epithelial cells produce laminin A, and this
can interact with laminins B and C produced by the mesenchyme to form a basement
membrane (Thomas and Dziadek , 1994). Nidogen cross links the laminins, collagen
IV, and heparan sulfate to form a stable structure (Paulsson et al., 1987; Aumailley
et al., 1989; Battaglia et al., 1992). The basement membrane at the tips of epithelial
buds is discontinuous, and epithelial and mesenchymal cells are seen interacting
via cellular projections through the basement membrane (Riso, 1983; Gallagher ,
1986). Collagen bundles are arranged parallel to epithelial stalks and are often found
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associated with endothelial cell clusters (Hilfer , 1996; Thomas and Dziadek , 1994).
Fibronectin deposition is key to the formation of epithelial branchpoints by reducing
cell adhesion, and knockdown of bronectin reduces branching (Sakai et al., 2003;
Onodera et al., 2010; De Langhe et al., 2005).
Thus, a myriad of morphogens as well as interactions between epithelium, the
surrounding mesenchyme, basement membrane components, and developing blood
vessels contribute to regulating lung branching morphogenesis. In addition, neurons
are known to be present within the lungs shortly after the branching program begins
(Burns et al., 2008; Tollet et al., 2001; Sparrow et al., 1995). As branching proceeds,
ganglia of neural cell bodies coalesce, and a network of nerves extends down the
growing epithelial tubules to innerve vascular and bronchial smooth muscle. However,
it remains unknown whether these nerves may be playing a role in regulating epithelial
branching itself. It has recently been demonstrated in a similar branching organ, the
submandibular gland, that parasympathetic innervation is necessary for growth and
branching of the epithelium (Knox et al., 2010). Therefore, we set out to investigate
the role of neurons in the early branching program of the lung.
7.2 Methods
7.2.1 Lung explant culture
Lungs were explanted from embryos at the desired stage of development and cultured
at the air-liquid interface on culture inserts as previously described (Aguayo et al.,
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Table 7.1: Concentrations of drugs and dyes used for lung branching studies.
Substance [Stock] [Final] Product Info
4-DAMP 25mM in DMSO 10 to 20M Tocris Biosci 0482
Heparin 2mg/mL in H2O 50ng/mL Sigma H3393
rmFgf10 100g/mL 400ng/mL R&D 6224-FG-025/CF
Topro3-iodide 1mM 1M Life Technologies T3605
1994; Jesudason et al., 2000). Briey, the embryonic lungs were gently separated from
the esophagus and heart in phosphate buered saline (PBS) at room temperature.
They were transferred in a small volume of PBS to a 0.4m Millicell polytetrauo-
roethylene culture insert using a pipet with the tip cut to enlarge the opening. The
lungs were carefully arranged to lie relatively at on the insert, and excess PBS was
removed, leaving a small volume of uid around the lungs. The insert was placed in a
6-well culture dish oating on top of 1.5 to 2mL of 50% DMEM-50% F12 media plus
2% fetal calf serum (FCS) and 100U penicillin/100g streptomycin (1:100 dilution).
Explants were cultured at 37 degrees Celsius with 5% CO2. Fresh media was provided
approximately every 24 hours.
7.2.2 Drug treatment of lung explants
Lungs were explanted and placed on culture inserts as described. The appropriate
amount of desired drug was diluted into the media in the culture well.
7.2.3 Wideeld imaging of lung explants and morphometry
Wideeld transilluminated and epiuorescent images of cultured lung explants were
captured with an Olympus stereoscope. The number of buds were counted to quantify
the extent of branching, and the fold change in number of buds was calculated.
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7.2.4 Laser ablation
Lungs were placed in a small volume of media in coverslip-bottomed imaging dishes.
The ablation procedure was limited to one hour per sample, and then the lungs were
quickly returned to culture at the air-liquid interface on culture inserts. Ablations
were performed using a long-working-distance, high-numerical aperture objective for
a small focal volume with a digital zoom of 3x. A z-stack was rst collected with
confocal imaging using 488nm wavelength light from an argon laser. The same region
was then imaged with low intensity 820nm infrared light with a pulse frequency of
80MHz from a titanium-sapphire laser. The collimating lens for the infrared light
was adjusted until the focal plane was the same as for the 488 nm visible light. A
nerve or axon of interest was then identied with confocal imaging, and a small region
of interest was drawn within the cell or axon. That region of interest was imaged
with approximately 350 to 700mW of average power (30-60% power) at 820nm with a
pixel dwell time of 164s/px. The area was again imaged with 488 nm light to verify
liquidation of the target. The number of scans performed for an ablation was counted,
and the same number of scans was performed in a control ablation on another sample.
For control ablations, scattered mesenchymal cells were targeted. Epithelium, blood
vessels, and nerves were avoided.
7.2.5 Topro cell death assay
1M of Topro3 iodide was added to lung explant media right before targeted abla-
tion was performed and immediately before each subsequent timepoint after culture.
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Topro3 iodide 642 was excited with 633nm light and was well separated from eGFP
emission.
7.2.6 Antibodies used
Table 7.2: Antibodies used for mammalian lung or Drosophila studies.
(DSHB= Developmental Studies Hybridoma Bank)
Antibody target Dilution Product Info
3-tubulin 1:250 Covance MMS-435P
Cleaved caspase 3 1:500 R&D AF835
E-cadherin 1:100 BD Pharmingen 610181
Fasciclin II 1:3 DSHB 1D4
eGFP 1:1000 Invitrogen A11122
HNK1 1:50 DSHB 3H5
Isotype specic donkey secondary antibodies 1:500 Invitrogen
Isotype specic goat secondary antibodies 1:500 Invitrogen
Phosphohistone H3 1:500 Millipore 06-570
QH1 1:50 DSHB QH1
Stranded at second 1:1000 D. Cavener, Vanderbilt U.
Tracheal lumen 2A12 1:2 DSHB 2A12
VEGFR2 1:25 BD Biosci 560680
7.2.7 Antibody staining of lung explants
Lung explants were xed with 4% crystalline PFA overnight at 4 degrees C then
washed 4 times with PBS to remove the PFA. Lungs were mounted in 3% agarose
and vibratome sectioned approximately perpendicular to the length of the explants
at a thickness of 75m. A vibrational amplitude of 8 and speed of 2.5 were used.
Sections were placed in Lab-Tek 8 well chambered slides and blocked for 3 hours
in blocking solution (PBS/0.8% TritonX-100/1%fraction 5 BSA/10% goat serum).
Primary antibodies were applied in fresh blocking solution overnight for 2 to 4 nights
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at 4 degrees C with gentle nutation. Primary antibody solution was removed and
sections were washed in PBS/0.3% TritonX-100 at room temperature 4 to 6 times over
approximately 4 hours and then overnight at 4 degrees C. Secondary antibodies were
applied at a 1:500 dilution in blocking solution overnight at 4 degrees C. Secondary
antibody solution was removed and sections were washed approximately 4 times over
4 hours at room temperature and overnight at 4 degrees C in PBS/0.3% TritonX-100.
Antibody staining of the lung explant in Figure 7.1A was performed as described
in Lazarus et al. (2011).
7.2.8 Imaging antibody-stained lungs
To image stained sections, the sections were mounted between two coverslips with
a small amount of PBS and placed on a copper slide holder for ease of ipping the
sample over to image both sides. Confocal and two-photon imaging were performed
with a Zeiss LSM 710 microscope with the following collection parameters: 5.5-6%
730 nm excitation, 371-455nm collection; 5.8-6.0% 488 nm excitation, 500-558nm
collection; 0.05% 561 nm excitation, 592-631nm collection; 0.8-3% 633nm excitation,
650-746nm collection. Identical settings were used across samples except when signal
was saturating, and then the laser power was adjusted to obtain comparable signal
at the surface and depth between samples. The pinhole size for confocal imaging was
4m, and the pinhole was open all the way for 2-photon imaging. The z-step interval
was 4m, and the pixel dwell time was 2.55s/px.
Whole mount xed avian lungs were mounted in 3% agarose, and extra agarose
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was trimmed parallel to the ventral or dorsal lung surface. To image the whole lung,
confocal and two-photon microscopy were used on parallel collection tracks to image
approximately 150m of the surface of the sample with overlapping tiled z-stacks.
Approximately 75m was then removed from the imaged surface with a vibratome,
and the process was repeated to image the next section. Overlapping z-stacks were
stitched using Fiji plugins (Preibisch et al., 2009).
Imaging of the lung explant in Figure 7.1A was performed as described in Lazarus
et al. (2011).
7.2.9 Confocal imaging of live lung explants
Lungs were placed in coverslip-bottomed imaging dishes in a small amount of media
and imaged with a Zeiss LSM 510 meta or Zeiss LSM 710 microscope. A 488
nm wavelength from an argon laser was used to image eGFP. To image multiple
uorophores in combinatorial antibody staining, two-photon excitation at 730 nm
was used to excite A350 dyes, 488 nm was used for FITC or A488 dyes, 561 nm was
used for A568 and A594 dyes, and 633 nm was used to excite A633 and A647 dyes,
and bandpasses were set to collect non-overlapping emissions. A Plan-Apochromat
20X/0.8 NA air or LD C-Apochromat 40X/1.1 water objective were used with a
pinhole set to 4-6.8m. Tiled z-stacks of images were collected with a pixel dwell
time of 2.55 to 3.22s and a z-interval of 2 to 6m.
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7.2.10 Statistics
Individual cells were counted in antibody-stained sections, and numbers were normal-
ized by the volume of tissue imaged. Ratios were calculated for the treatment group
compared to the controls. Means and standard errors of the mean were calculated
and plotted using MATLAB. Endothelial cell cluster sizes were also plotted using
MATLAB. Statistical signicance in dierences in branching of lung explants was
determined by the Mann-Whitney U test for continuous variables that may or may
not have a normal distribution.
7.2.11 Fly crosses
For pan-neural ablation, the elav -gal4 driver line was crossed to the UAS-RicinA/CyO
line. Embryos with neural ablation were clearly distinguishable from normal embryos
with no ablation by neural antibody staining. To visualize the cells aected by this
ablation, the elav -gal4 driver line was crossed to the UAS-dsRed stinger line, which
expresses nuclear dsRed in cells expressing the driving promoter following heat shock.
Embryos were collected on grape jelly plates in egg-laying chambers and kept moist
until they had developed to the stage of interest. For the UAS-dsRed cross, embryos
were heat shocked for 2 hours at 29 degrees Celsius ve hours before imaging to
activate the nuclear dsRed expression, and then they were imaged live 3 hours later.
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7.2.12 Drosophila embryo xation
For whole mount preparation, when embryos reached stages 13 to 16, they were
transferred to glass vials and treated with heptane and 5% PFA in PBS for 15 minutes
at room temperature to x. The PFA was removed and 100% methanol was added,
and the embryos were shaken to remove the vitelline membrane. The heptane was
aspirated and the embryos were incrementally rehydrated through 70%, 50%, 30%,
0% methanol in PBS and then transferred to PBT (PBS + 0.05% TritonX-100 +
0.1% BSA).
7.2.13 Drosophila embryo antibody staining
For antibody staining, embryos were blocked for 1 hour at room temperature in 5%
normal goat serum (NGS) then incubated with primary antibodies in PBT + 2%
NGS overnight at 4 degrees C. Embryos were washed 6 times for 30 minutes at room
temperature in PBT then blocked for 20 minutes in 5% NGS. Secondary antibodies
(Invitrogen) were used at 1:500 in PBT + 2% NGS overnight at 4 degrees C. Embryos
were washed 6 times for 30 minutes at room temperature and transferred to PBT/14%
glycerol.
Fillet preparations were performed as previously described (Lee, 2009). Briey,
following drug treatment embryos were spread on glass slides with guts removed and
a wax line drawn around them on the slide. They were xed in 5% PFA for 30
minutes at room temperature and washed 4 times for 5 minutes in PBS and again
in PBT on the slides. Blocking was performed for 30 minutes in 5% NGS, and llets
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were incubated with primary antibodies as above at 4 degrees overnight. Fillets were
washed 6 times for 10-30 minutes and incubated with secondary antibodies as above
at 4 degrees overnight, then washed again 6 times for 10 minutes. Coverslips were
mounted and sealed with nail polish.
7.2.14 Imaging of Drosophila embryos
Whole mount Drosophila embryos were arranged on glass slides with permauor (for
xed embryos) or PBS (for live nuclear dsRed labeled embryos) and coverslipped for
imaging. Coverslipped llet preparations were imaged the same way as whole mount
embryos. Confocal and two-photon tiled z-stacks were collected with a Zeiss LSM
510 meta or Zeiss LSM 710 microscope using a 2m pinhole (for confocal) and 1.5m
z-step interval. Appropriate excitation wavelengths and collection bandpasses were
selected as above for the uorophores used. Images were assembled using Fiji stitching
plugins (Preibisch et al., 2009) and viewed in 3D using Imaris software (Bitplane).
7.3 Results
To assess whether the intrinsic nerves of the lungs grow and elaborate with the
epithelial branching program during early pseudoglandular development, we studied
lung explants, which are detached from external inputs yet continue to branch in a
stereotyped fashion in culture. Explant culture also enables non-genetic perturbation
studies. To analyze the structure of the nerve network near the beginning of the
branching program, fresh lung explants from embryonic day E12.5 were stained with
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antibodies against E-cadherin to label the epithelium and 3-tubulin to label the
nerves (Fig. 7.1A). Axon tracks extend along the bronchial epithelium into each major
lobe of both lungs. The vagus nerve is also visible as the thick nerve bundle down
the center between the lungs.
We next determined whether the nerves are visible in live explants without the aid
of antibody staining. The microtubule-associated protein tau eGFP (MAPT) knockin
mouse line has eGFP inserted in the tau protein locus and labels all neuron cell bodies
and axons with eGFP (Tucker et al., 2001). Confocal imaging of live E12.5 lung
explants from these mice demonstrates that principle nerve bundles to each of the lung
lobes are clearly visible and comparable to the xed sample (Fig. 7.1B). In this sample,
the vagus nerve was removed for clarity. Explants were then cultured at the air-
liquid interface on culture inserts. Brighteld (Fig. 7.1C) and epiuorescence images
(Fig. 7.1D) are shown for a lung freshly explanted from a MAPT positive embryo at
E12.5. Figure 7.1E and F show brighteld and uorescence images, respectively, of
the same lung after 46 hours in culture. The nerve tracks to the primary lobes visible
in Fig. 7.1D continue to elaborate along the branched epithelial tubes in Fig. 7.1F
(examples marked by white arrowheads). Thus, even when disconnected from the
central nervous system, neurons persist in the lung and integrate with the branching
structure.
Branching of the submandibular gland depends on parasympathetic neural input
(Knox et al., 2010). To test whether inhibition of muscarinic acetylcholine receptors
aects branching during lung development as it does in the submandibular gland, lung
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Figure 7.1: Intrinsic nerves elaborate with epithelial branches in lung explants. (A)
lung explants from E12.5 mouse embryos were xed and stained with antibodies
against epithelial E-cadherin (white) and neural 3-tubulin (green) to visualize the
nerves within the lungs at this stage. Axon bundles are visible along each major
lobe. The vagus nerve is visible as the large nerve bundle in the center. (B) These
principal neural axons are visible projecting to each lung lobe in live lung explants
from the MAPT mouse line without using antibody staining. The vagus has been
removed for clarity. Lungs were then cultured to assess whether the nerves survive
following explant and continue to elaborate with the epithelium. A fresh explant
is seen in brighteld (C) and epiuorescence (D) to visualize the nerves. After 46
hours in culture, the same lung has branched considerably (E, brighteld). (F) By
epiuorescence, the nerves are still present and projecting axons along the epithelial
branches (examples indicated by white arrowheads). Scale bars=200m.
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explants were treated with or without the irreversible muscarinic inhibitor 4-DAMP
(N-2-chloroethyl-4-piperidinyl diphenylacetate) and cultured for two days. Various
concentrations of 4-DAMP were tested alone or in combination with heparin and
recombinant mouse Fgf10 branching morphogens, and in no case was an inhibitory
eect on branching measured. The panels in gure 7.2 show freshly explanted lungs
(A and B), where the lung in (A) was treated with 4-DAMP. Figure 7.2C is the
same lung after 21 hours in culture, and Fig. 7.2D shows the control lung after the
same time in culture. Although these explants were from the same mouse, there can
still be variability in the maturity of the individual embryos, and the control in B
began slightly less branched than the explant in (A). Therefore, the explant in C has
more branches than the one in D, but this is proportional to the starting maturity
of each lung. Even so, the muscarinic inhibitor caused no eect on lung branching.
Quantications are provided in Figure 7.7. The complexity of neurons present in the
lungs at this stage may be greater than in the submandibular gland, with disruption
of one type being compensated by other neural types. Alternatively, acetylcholinergic
signaling may not be important at this stage.
It is possible that a combination of inhibitors of dierent neural receptors could
elicit an eect on epithelial branching. However, a role for nerves in early lung
development may not involve signaling via neurotransmitters: the nerves could be
performing some other function. Acetylcholine receptors are also expressed by many
non-neural cells (Roman and Koval , 2009;Wessler and Kirkpatrick , 2001). Therefore,
to test whether the nerves play a regulatory role in bronchial epithelial branching
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Figure 7.2: Unlike the submandibular gland, inhibition of muscarinic receptors does
not aect lung branching. Explants were treated with or without the irreversible
muscarinic inhibitor 4-DAMP, alone or in combination with branching mediators
heparin and Fgf10. Freshly explanted lungs treated with 4-DAMP (A) or without
inhibitor (B) are shown. The same lungs after 21 hours in culture are shown following
culture with 4-DAMP (C) or without (D). At no concentration of 4-DAMP was an
inhibitory eect on branching measured. The lung in (C) has more branches than the
one in (D) owing to its slightly greater maturity upon explant despite coming from
sibling embryos of the same pregnant mother. The branching is proportional to their
starting maturity. Scale bars=200m.
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without regard to how they exert their inuence, a generic method of removing all
nerves regardless of subtype was necessary. For this reason, we looked beyond genetic
ablation, which might remove only a subset of nerves, and dierent subsets could be
more or less important and give unclear answers. Targeted laser ablation connes a
focus of high-energy infrared light to small focus of about 0.1m3. At a power of 350
to 700 mW, the beam can liquidate any cell at its point of focus.
We tested whether laser ablation was suciently powerful and precise to dener-
vate lung explants. Lungs from MAPT embryos were used to visualize the nerves.
Individual cell bodies or axons were identied with confocal microscopy, and a two-
photon laser at 820nm was collimated to the same focus point (Fig. 7.3A). A small
volume was scanned within a cell or across an axon (Fig. 7.3B, regions shown at
higher magnication are outlined). The region was then imaged again with con-
focal microscopy to assess the results. When a cell body was targeted, a ring of
autouorescence was often seen following ablation of each cell, or sometimes the cell
was no longer visible by uorescence (Fig. 7.3B-1). After targeting slices across an
axon, distal eGFP uorescence that was previously visible in the axon was dissipated
(Fig. 7.3B-2). These results suggested that targeted two-photon laser ablation could
eliminate cells from live explants.
To test the precision of the laser ablation technique, a stack of confocal images was
taken to assess the positions of multiple cells in three dimensions (Fig. 7.4). A neuron
was selected for ablation where there was a second neuron positioned one cell width
directly behind it in the axial dimension. Figure 7.4A shows the targeted neuron in
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Figure 7.3: High energy two-photon laser power can eliminate cells from explants. (A)
Neurons were identied in MAPT lung explants by eGFP uorescence with confocal
microscopy. 820nm infrared light was focused to the same plane to target cell bodies
or axons. (B) Neurons were imaged before and after ablation. Cells or axons in the
boxed regions of the top panel were targeted and are shown at higher magnication
following ablation. (B1) After targeting cell bodies, either a ring of autouorescence
is seen, or the cell is no longer visible by uorescence imaging. (B2) After slicing
axons, the eGFP is dissipated distal to the cuts (yellow arrow).
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the X-Y plane before the ablation, with the red circle indicating the ablation focus.
Figure 7.4B shows the axial plane with the neuron to be ablated marked in red, and
the white arrow indicates the neuron directly behind it. Figure 7.4C-D show the same
image volume after ablation. Viewed in the X-Y plane ( Fig. 7.4C), a vaporization
ring of autouorescence is seen where the targeted neuron had been (outlined by red
box). In the axial dimension (Fig. 7.4D), the vaporized neuron is outlined in red, and
the neuron positioned directly behind it has been unaected by the adjacent ablation
(white arrow). Thus, the energy of the ablation is tightly conned to the focus and
does not cause immediate damage to nearby cells.
To determine whether heat from the ablation aects bystander cells after a longer
period of time, cell death was assessed immediately after ablation and up to 4
hours later. A lung explant was treated with Topro3 iodide dead cell indicator to
uorescently label dead cells with a uorophore that is spectrally distinct from eGFP.
Figure 7.5A shows a projection of an image stack collected of a neuron of interest
before ablation. The yellow arrow indicates the cluster of cells to be ablated, and the
yellow line marks the laser focus region. Immediately after ablation, a second image
stack was collected (Fig. 7.5B). The cells targeted by the ablation are no longer visible,
but the adjacent axon remains. The lung was cultured and then re-imaged after two
and four hours, with fresh Topro-3 added each time to label dead cells. Figure 7.5C
shows the same region of interest after 4 hours when cell toxicity from the ablation
would be apparent. A few cells at the point of focus of the ablation are permeable
to the indicator (purple). However, there is not general toxicity to bystander cells in
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Figure 7.4: Targeting a region of interest within a single cell connes the ablation to
that cell. (A) Before ablation, a neuron of interest is shown in the X-Y plane with
the red circle indicating the ablation focus. (B) The same neuron is marked in red in
the axial plane, and a neuron positioned directly behind it is indicated by the white
arrow. (C) Following ablation, a ring of autouorescence marks where the targeted
cell had been (red box outline). (D) Viewed axially, the ablated cell is outlined in
red, and the adjacent neuron behind it is unaected (white arrow). Scale bar=20m
throughout.
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Figure 7.5: Bystander cell death is not observed hours after ablation. Death of
neighboring cells in the region of a targeted ablation was assessed up to 4 hours
after ablation. A MAPT lung explant was treated with Topro3 dead cell indicator to
visualize dead cells. (A) A projected image stack shows a cluster of cells and axons
before ablation, with the yellow arrow pointing to the cells that will be targeted and
the yellow line indicating the region of laser focus. (B) An image stack was collected
immediately after ablation, and the targeted cells are no longer visible by uorescence
imaging. (C) After 4 hours in culture, the explant was freshly treated with Topro3
and the same region of interest was imaged. A few dead cells are permeable to the
indicator where the ablation was performed (purple), but there is not generalized
death of cells in the surrounding area. Scale bar=30m throughout.
the surrounding region. The same results were observed after 2 hours in culture.
To assess whether the presence of nerves is necessary for bronchial epithelial lung
branching, nerves were laser ablated from MAPT lung explants. Individual neurons
and axons were targeted in either the left or right lung of an explant until all or
nearly all visible neurons had been lased. To control for the loss of cells and localized
heat damage from the ablations, a control ablation was performed on another lung
explant from an embryo of the same litter. For these controls, the same lung (right
or left) was targeted as in the ablated sample, but instead of hitting neurons or
axons, an equivalent number of scattered mesenchymal cells were ablated. Blood cells
could often be identied by brighteld morphology, and the epithelium was visible
by brighteld, so neurons, endothelial cells, and epithelium were avoided. Control
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ablated and nerve ablated explants were then cultured for 43 to 46 hours on culture
inserts. Individual epithelial branches were counted immediately after ablation and
following 23 and 43-46 hours in culture.
Figure 7.6 shows images of ablated and control ablated lung explants taken at
the time of ablation and after two days in culture. The nerves of the left lung in the
explant in Fig. 7.6A were ablated. Red asterisks mark the locations of terminal buds
present at the time of ablation, and black asterisks mark the positions of terminal
buds in the untouched right lung, which serves as a culture control. Fig. 7.6B shows
the same lungs after approximately two days in culture. The red asterisks mark the
same buds that were present in the fresh explant of the left lung from which nerves
were ablated. Black asterisks serve as place holders to mark the positions of the distal
buds that were present in the right lung of the fresh explant in (A). It is clear that in
the right lung, the epithelium has continued to branch, and numerous distal buds are
visible beyond the black asterisks. In contrast, the left lung has grown very little, and
only one branch has extended. The epithelium is still clearly visible, which it would
not be if the explant had died. Figure 7.6C diagrams the branches that were present
in the fresh explant (black) and the new branches that formed during the two days
in culture (green). While the right lung branched considerably, the left lung changed
very little.
Figure 7.6D-F show the equivalent panels for a stage-matched explant on which
a control mesenchymal ablation was performed on the left lung. Black asterisks
mark the distal positions of buds present in the fresh explant (Fig. 7.6D). The same
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explant is seen after two days in culture, and both lungs have continued to branch
(Fig. 7.6E). The new buds that formed are illustrated in green in Figure 7.6F. The
right lung branching of the ablated sample (Fig 7.6C) is comparable to the right lung
branching of the control (Fig. 7.6F).
Nerve ablation was then performed on the right lung instead of the left. Fig-
ure 7.6G-H show the explant at the time of ablation and after two days in culture,
respectively. Red asterisks mark the distal buds that were present in the right lung
of the fresh explant, while black asterisks mark the untouched left lung (Fig. 7.6G).
In Figure 7.6H, the asterisks again serve as place holders marking the buds that were
originally present in the right ablation lung (red) and left culture control (black).
The right lung has not branched beyond its original structure, while the left lung
has continued to branch substantially, as illustrated by green branches in Figure 7.6I.
A right lung control mesenchymal ablation was similarly performed, and the black
asterisks mark the positions of identical branches at the time of ablation and after two
days of culture (Fig. 7.6J-K). As with the left sided control (Fig. 7.6E-F), the right
lung control continues to branch proportionally to the unaected left lung (Fig. 7.6K-
L).
These results demonstrate that heat damage from the ablations and elimination
of scattered mesenchymal cells from the lungs does not inhibit lung branching. These
lungs continue to branch like unperturbed lungs. In contrast, lungs from which the
nerves were ablated cease to branch, suggesting that the nerves play a necessary role
in enabling epithelial branching.
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Figure 7.6: Nerve ablation halts lung branching while ablation of scattered mesenchy-
mal cells does not inhibit branching. (A) Nerves were ablated from the left lung of the
explant, and the right lung was not manipulated. Red asterisks mark the terminal
buds of the left lung at the time of ablation, and black asterisks mark terminal buds
in the right lung. (B) The same lung is shown after 43-46 hours in culture, with red
asterisks marking the positions of the buds that were present in the left lung two days
prior, and black asterisks serving as place holders for the branches that were originally
present on the right. Numerous new branches have formed on the right lung distal
to the black asterisks, while on the left lung only one branch has extended slightly.
(C) The diagram illustrates the branches that were present upon explant (black) and
the new branches that formed in culture over two days (green). (D) In parallel, an
equivalent number of scattered mesenchymal cells were ablated from the left lung of
a stage-matched explant from a sibling embryo to control for heat damage and cell
loss. Epithelium, neurons, and endothelium were avoided. Black asterisks mark the
terminal buds on the right and left lungs. Caption continued next page.
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Figure 7.6: (Continued from previous page.) (E) The explant is seen after two days
in culture with black asterisks indicating where the terminal branches had been in
the fresh explant. Both lungs, including the left lung with the control ablation,
continued to branch substantially, as illustrated in the schematic (I). (G-L) show the
same ablation and control ablation for right lung, where the nerves were ablated from
the right lung in (G), and a control ablation was performed on the right lung in (J).
Like the left lung, nerve ablation in the right lung halts branching (H,I). The left lung
paired with the right lung nerve ablation has branched substantially (H,I), as have
both lungs of the control ablation sample (K,L). Scale bar=200m throughout.
The extent of branching for ablations and controls was quantied by counting
epithelial branches and calculating the fold change. Figure 7.7 plots the fold change
in number of branches. The median change in branches for lungs from which the
nerves were ablated was 1.4, while the median fold change for the control ablations
was 3.3 (Fig. 7.7A, red lines indicated medians). The p value for statistical dierence
between these is much less than 0.01 (Mann-Whitney U test for non-parametric pop-
ulations). In comparison, the median fold change in branching for explants cultured
with the muscarinic inhibitor 4-DAMP was 4.5, and the median for controls that were
cultured with no inhibitors or ablations was 3.9. There is no statistical dierence in
branching for samples treated with muscarinic inhibitor compared with controls, nor
is there any statistical dierence in branching between control mesenchymal ablation
samples and explants cultured without any perturbation. These results indicate that
neurons are necessary for lung epithelial branching, but their role is independent of
parasympathetic muscarinic signaling.
To test whether a genetic neural ablation could produce a lung branching pheno-
type resembling that from nerve ablation, branching was quantied in lung explants
from endothelin B receptor (EDNRB) knock-out mice. EDNRB knock-out mice have
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Figure 7.7: Nerve ablation causes a statistically signicant blockade of lung branching,
while control mesenchymal ablation has no aect on branching. Lung buds were
counted in fresh explants and after two days in culture, and the fold change in
branching was calculated. (A) The median fold change in branches for lungs following
nerve ablation was 1.4 compared with 3.3 for control ablations (p value signicantly
less than 0.01 by Mann-Whitney U test). (B) No signicant dierence in branching
was found for lungs treated with the muscarinic acetylcholinergic inhibitor 4-DAMP
compared to controls. There was also no statistical dierence in branching between
control ablated lungs and lungs that were simply cultured with no perturbation. Red
lines indicate median values.
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Figure 7.8: Partial lung denervation by genetic knock-out of endothelin receptor B
(EDNRB) does not aect lung branching. Lungs were explanted from wild type,
heterozygous, and EDNRB knock-out litermates and cultured for two days. Fresh
explants from wild type (A) or EDNRB-/- (C) embryos were cultured for 43-46 hours.
Cultured wild type (B) and EDNRB-/- (D) branch comparably. (E) Quantication
of branching shows no dierence between wild type, heterozygous, and knock-out
littermates. Scale bars=200m. Red lines indicate median values.
an aganglionic gut and are reported to have reduced but not eliminated lung inner-
vation (Hosoda et al., 1994). Lung explants from wild type, heterozygous (+/-), and
EDNRB knock-out (-/-) mice were cultured as before. Lungs from EDNRB knock-
outs branched just as much as those from heterozygote and wild type littermates
(Fig. 7.8A-D). Quantication of the fold change in branches showed no dierence
between the three groups (Fig. 7.8E). Either the subtype of nerve matters at this
stage of development, or an insucient number of neurons were eliminated by genetic
ablation.
Antibody staining was performed on the nerve ablation lung explants and control
ablation lung explants to investigate what cell behaviors might account for the mea-
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sured dierences in branching. Figure 7.9A shows a projected z-stack of a section from
a control ablation lung, and Figure 7.9B is from a nerve ablation lung. Phosphohistone
H3 staining for proliferation (pink), 3-tubulin staining for nerves (cyan), and Vegfr2
staining for endothelial cells (green) are all less frequent in the denervated samples.
Quantication of the nerves found in the lung sections from each treatment group
demonstrates that the number of nerves in the nerve ablation samples are indeed
severely reduced to 6% of that found in controls (Fig. 7.9C).
Cell proliferation in the epithelium and mesenchyme of lungs following nerve
ablation is also reduced, which is consistent with the reduced size of these lungs
relative to controls. Total cell proliferation in samples with nerve ablation is 20% of
that in control ablated samples (Fig. 7.9D). Interestingly, the number of endothelial
cells observed in lungs following nerve ablation is also substantially reduced to 27%
of that in control ablated lungs. The endothelial cells that are present in the nerve
ablated lungs are typically in smaller clusters, while large clusters of cells are seen in
the control ablation samples. Figure 7.9F shows the frequency of dierent endothelial
cell cluster sizes present in the two groups. Quantication of the proportion of
endothelial cells from each group that are dividing will shed light on whether a
proliferation defect in the endothelia accounts for their reduced numbers in lungs
denuded of nerves. Preliminary assessment of cell death suggests it is not dierent
between control and denervated samples.
Neurons may play a conserved role in regulating branching morphogenesis during
development. In Drosophila, the tubular tracheal system for air transport is homolo-
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Figure 7.9: Caption next page.
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Figure 7.9: Laser ablation denervates the lung and results in fewer endothelial cells
and reduced proliferation. Control ablated and nerve ablated lungs were sectioned
and stained with antibodies against phosphohistone H3 for proliferating cells (pink),
neural 3-tubulin (cyan), and endothelial Vegfr2 (green). Panels show a sample from
(A) a control ablated lung and (B) a nerve ablated lung. (C) Nerves are indeed largely
eliminated following targeted neural ablation. On average, they are reduced to 6%
of the amount seen in controls. (D) In nerve ablated samples, cell proliferation is
reduced to a mean of 20% of that of control ablated samples, which is consistent with
the lungs being smaller. (E) Fewer endothelial cells are present in denervated samples,
with on average only 27% as many observed as in controls. (F) shows the distributions
of endothelial cell cluster size for each treatement group. The endothelial cells that
are present in denervated lung explants are found in smaller clusters, whereas in
controls, large groups of endothelial cells are often seen. Scale bars = 50m. Error
bars represent the S.E.M.
gous to the mammalian lung, and development of the trachea is regulated by many of
the same factors that have been characterized to direct mammalian lung development
(Aolter et al., 2009; Cardoso and Lu, 2006; Glazer and Shilo, 1991; Hacohen et al.,
1998; Horowitz and Simons , 2009; Morrisey and Hogan, 2010; Sutherland et al., 1996;
Warburton et al., 1998, 1999, 2000). To assess whether neurons are necessary for
proper embryonic tracheogenesis in Drosophila, neurons were genetically ablated. The
elav promoter is expressed in all neurons for neural dierentiation (Yao and White,
1994). The A subunit of the Ricin toxin is a potent inducer of cell death by blocking
protein translation (Hidalgo and Brand , 1997). The elav:Gal4 driver line was crossed
with the UAS-RicinA line to kill neurons. Neural death is expected to begin around
stage 11, in time to aect tracheogenesis at stages 12-16.
Figure 7.10A shows a wild type Drosophila embryo at approximately stage 16,
stained with antibodies against tracheal lumen protein and neural cell adhesion
molecule Fasciclin II (FasII), which labels longitudinal tracks of the central nervous
system and some motor axons. Figure 7.10B depicts all the cells expressing the
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elav promoter by uorescent label of their nuclei. Neural cell bodies positioned
in the central nervous system are visible as a large collection in the region around
the longitudinal fascicles, and peripheral nerve cell bodies are visible in each body
segment. All of these cells express the elav promoter.
When RicinA is expressed in neurons under the control of the elav driver, neurons
are ablated to varying degrees, but generally many neurons are killed. Concomitantly,
tracheal morphogenesis is disrupted. Figure 7.10C-F show examples of embryos
expressing the RicinA toxin under the control of the elav promoter in neurons.
Compared with the wild type embryo in Figure 7.10A, the longitudinal fascicles are
typically missing and replaced with short sections of labeled axons (Fig. 7.10D,E, open
arrowheads). Some embryos possess one or more fascicles, but they are abnormal. In
Figure 7.10D, a single fascicle on each side extends along most of the embryo, but it
is broken in sections (arrowheads) and has disordered commissures. In Figure 7.10F,
the longitudinal tracks are present but mostly fused together (arrowheads), and the
peripheral FasII-positive projections are highly disordered.
Deletion of neurons causes are range of perturbations of tracheal development. In
the embryo in Figure 7.10C, cells appear to have formed fragments of a dorsal tube,
but it is discontinuous, and it is actually positioned on the ventral side of the embryo
instead of the dorsal side (arrows). Similarly, in Figure 7.10D, short tracheal tubes
are present by lumen label, but they are discontinuous (arrows). Smaller branches
are not evident by lumen staining. In Figure 7.10E, some smaller tracheal tubes have
formed and lumenized but are discontinuous (closed arrowheads). Most of a dorsal
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trunk is present, but it also has a break (arrow). In Figure 7.10F, the tracheal cells
appear to have all clustered into two groups and formed a circuitous ball of lumen
(arrows), which is highly abnormal. These phenotypes cannot be a result of toxin
being released from dying cells and acting directly on bystander cells because only
the A subunit of the toxin is expressed. The B subunit is required to gain entry to
viable cells, so any released toxin will have no eect.
To conrm that tracheal cells are indeed misplaced or absent in these mutants and
that the defect is not solely in lumenization, embryos were stained with antibodies
against the lumen protein as well as an antibody against stranded-at-second, which
labels the tracheal epithelial cells. Figure 7.10G shows the lumen label in a less
severely perturbed mutant, which has more tracheal tubes to analyze. Figure 7.10H
shows the tracheal epithelial cells, and Figure 7.10I is the merge. Epithelial cells
indeed surround the discontinuous lumens (arrowhead) and are absent where gaps are
evident by lack of lumen label (arrow). Thus, deletion of neurons during Drosophila
embryonic development disrupts tracheal morphogenesis and branching. A role for
neurons in proper execution of stereotyped branching is conserved from mammalian
lung to Drosophila tracheal development.
7.4 Conclusions and Discussion
Neural cell bodies reside within the lung and form ganglia and networks of axons
that extend along the bronchial tubules as the epithelium grows and branches during
embryogenesis. These neurons play a necessary role in the progression of iterative
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Figure 7.10: Caption next page.
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Figure 7.10: Neurons are required for Drosophila embryonic tracheal development.
Neurons were ablated in Drosophila embryos by expressing the A subunit of the potent
ricin toxin under the control of the pan-neural driver elav. Antibody staining for the
FasII adhesion molecule labels the longitudinal tracks of the CNS and some motor
nerve axons (magenta). Tracheal structure is visible by staining for lumen protein
(cyan). (A) shows the neural and tracheal structure in wild type embryos. (B) Neural
nuclei are labeled by the activity of the elav promoter to visualize the distribution of
cells aected by the ricinA toxin. (C-F) show examples of neural depletion and the
eects on tracheal development when ricinA is expressed in neurons. The longitudinal
tracks often nearly eliminated ( C,E open arrowheads) and sometimes reduced to
single disordered tracks with breaks (D, open arrowheads) or merged tracks with
disordered peripheral projections (F, open arrowheads). Sections of what appear to
be dorsal tracheal trunk form but are fragmented with breaks (C-E, arrows). In
(C), the these tracheal cells are actually positioned on the ventral side of the embryo
rather than the dorsal side. Smaller tubes are largely absent by lumen staining, and
those that are present are incomplete (E, closed arrowheads). In (F), the tracheal
cells form circuitous balls of lumenized tube, which are severely abnormal (arrows).
(G-I) show labeling of tracheal epithelial cells in llet preparations to conrm that
the gaps are not simply a lumenization problem. Discontinuous tracheal lumens (G)
are surrounded by epithelial cells (H) and seen together in the merge(I) (example
indicated by arrowheads). Where gaps in the lumen exist, epithelial cells are absent
(G-I, arrow). Scale bars=50m throughout.
branching. Targeted laser ablation is precise and eective at eliminating individual
neurons without causing detectable damage to surrounding cells. Deletion of the
pulmonary neurons, but not scattered mesenchymal cells, halts epithelial branching.
Inhibition of muscarinic receptors does not reproduce the branching phenotype, which
contrasts with the submandibular gland. Neither does partial genetic denervation
cause a branching defect. Elimination of the neurons signicantly reduces the number
and cluster size of endothelial cells in the lungs. Quantication of endothelial cell
proliferation and apoptosis will reveal whether a proliferative or survival defect,
or both, account for the reduced number of vascular cells. Similarly, proliferation
of the epithelium and mesenchyme is also compromised in denervated lungs. The
requirement for nerves in epithelial branching extends to the embryonic Drosophila
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tracheal system, where substantial ablation of neurons leads to severe disruption of
tracheaogenesis, often with only a few sections forming, and sometimes at the wrong
position in the embryo.
Partial pulmonary denervation by genetic ablation did not recapitulate the eects
of more complete denervation by laser targeting. This suggests that the subtypes of
neurons may matter, or they may be able to compensate among themselves, requiring
ablation of a certain proportion of the total population of neurons to inhibit branching.
The reduction in the number of endothelial cells could partly be a result of
perturbed endothelial cell migration. Neurons and endothelia interact via ephrins,
neuropilin, and other guidance signals (Aolter et al., 2009; Bagnard et al., 2001;
Melani and Weinstein, 2010). If the pulmonary nerves provide a scaold for mi-
gration of endothelial cells and assembly of vessels to form parallel neurovascular
bundles, then elimination of the nerves would be expected to result in fewer endothelia
populating the lung parenchyma. Indeed, in embryonic avian lungs, neurons and
undierentiated neural cells that may become glial cells are seen interacting with
disorganized endothelial tubules early during lung bud outgrowth from the foregut
(Fig. 7.11A, arrows). As the lung matures, progressively more organized networks
of nerves and blood vessels align and form a meshwork around distal epithelial
tubes (Fig. 7.11B). Cell-cell contacts between endothelial cells and neurons are likely
involved in the organization of these networks. This is consistent with descriptions
of neurovascular tracks observed in fetal mammalian lungs (Sparrow et al., 1999).
Neurons may also provide growth and survival signals, such as Vegf-A, to stimulate
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Figure 7.11: Neural and vascular cells interact during early avian lung development
and align to form a neurovascular network. Antibody staining for neural crest cells
(HNK1, purple), nerve axons (3-tubulin, cyan), endothelial cell membrane (QH1,
red), and endothelial nuclei (tg(tie1 :H2B-eYFP), green) was performed on lung
explants from E3.5 and E7 quail embryos. (A) In E3.5 quail lungs, which consist of
two primary bronchi, vascular tubes are forming, and endothelial cells are seen making
contact with clusters of neurons (arrows). Neurovascular structure is disorganized.
(B) In E7 quail lungs, organized networks of mostly aligned nerves and blood vessels
extend down branched epithelial tubes (which are situated in the unlabeled regions
of the image).
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endothelial survival, proliferation, and vessel sprouting. It is known that reduction of
pulmonary vasculature using a VEGF decoy receptor perturbs the epithelial branching
program: the extent of branching is reduced overall, and in particular, orthogonal
branches that thicken the lung structure form less frequently and at more shallow
angles, even in explant cultures disconnected from circulation (Lazarus et al., 2011).
Airways are also more dilated from continued epithelial proliferation. Thus, some
of the perturbation of epithelial branching may be an indirect result from disrupted
vasculogenesis. However, epithelial ramication is halted following pulmonary dener-
vation, which is not observed by vascular ablation. Thus, pulmonary neurons must
be necessary for additional aspects of lung development beyond vascularization.
VEGF blockade results in diuse Fgf10 expression (Lazarus et al., 2011). Elimi-
nation of neurons may deplete an important source of Vegf-A, and this could in turn
disrupt Shh signaling in the epithelium to generate diuse Fgf10 expression through
the mesenchyme, rather than localized Fgf10 production at the tips of growing buds.
Analysis of Fgf10 distribution in denervated explants should elucidate whether this
may be a factor in the blockade of branching. Mesenchymal proliferation is also
compromised, and if mesenchymal function is perturbed then less Fgf10 may be
produced. Gene expression studies should shed light on how epithelial-mesenchymal
signaling may be altered.
Exogenous nicotine stimulates lung branching after long-term exposure (Wong-
trakool et al., 2007). 3 and 4 nicotinic acetylcholine receptors (nAChRs) are
expressed on pulmonary nerve bers at the stage of interest (Fig. 7.12). Nicotinic and
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muscarinic acetylcholine receptors are also expressed by many non-neural cell types,
including pulmonary endothelia, broblasts, macrophages, neuroendocrine cells, and
bronchial epithelium, where they modulate calcium and aect cell motility and ad-
hesion (Conti-Fine et al., 2000; Wessler et al., 1999; Wessler and Kirkpatrick , 2001;
Zia et al., 1997). However, nicotinic inhibitors do not inhibit epithelial branching
(Wongtrakool et al., 2007). So it is unlikely that the endogenous role of nerves during
early lung development is to provide acetylcholine. Instead, exogenous nicotine (such
as from smoking during pregnancy) acts through nAChRs that are expressed on the
epithelium and other cell types, but this activity is extrinsic to normal development
(Catassi et al., 2008; Jensen et al., 2012; Li et al., 2011).
While muscarinic acetylcholine receptor (mAChR) blockade in the mouse sub-
mandibular gland was sucient to interrupt epithelial branching in that organ (Knox
et al., 2010), it caused no eect on pulmonary branching. Considering that nAChR
blockade also does not impede branching, either all neural activity must be simul-
taneously blocked, or the neurons are important for another purpose besides neu-
rotransmitter release. Since many dierent cell types express ACh receptors, a
role for neurotransmitter signaling cannot be determined using receptor inhibitors.
Botulinum toxin could be used to block neurotransmitter release at acetylcholinergic
nerve terminals to clarify if neurotransmitter signaling is important for epithelial
branching (Schiavo et al., 1992; Rossetto et al., 2001).
During limb regeneration in salamanders, nerves are necessary for dedierentiation
of blastema cells and growth of a new limb (Bryant et al., 2002). In this system,
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Figure 7.12: Nerves with 3 and 4 nicotinic acetylcholine receptor (nAChR) subunits
are expressed on pulmonary nerve bers during early lung development. Lungs were
explanted from E12.5 embryos of mice with eGFP-tagged nicotinic receptor 3 or
4 subunits and imaged with confocal microscopy. (A) shows a whole lung with 3
nAChR positive nerve bers around the trachea and extending into the individual
lung lobes. The large vagal nerve is also labeled. Higher magnication shows 3 (B)
and 4 (C) positive axons and cell bodies along the bronchial tubes.
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nerves produce and secrete transferrin, which binds and transports iron in the blood
for uptake into cells (Mescher et al., 1997). Exogenous transferrin is sucient to
support limb regeneration in the absence of nerves. It is possible that neurons in the
developing lung provide transferrin or another growth-promoting molecule to directly
support epithelial proliferation and branching.
Neural ablation also impedes proper embryonic Drosophila tracheal morphogen-
esis. In this system, the nerves may serve as a scaold for tracheal epithelial cells
to migrate along to reach their proper destinations. This hypothesis is supported
by the formation of what appears to be a partial dorsal trunk at the ventral side of
a nerve ablated embryo (Fig.7.10C) and fragments of a trunk at the tips of motor
nerve projections that do not extend all the way to the dorsal part of the embryo
(Fig.7.10D). The nerves may also provide a growth and migratory promoting signal
as in the mammalian lung. Specic ablation of peripheral nerves may clarify if these
are the axons necessary for proper tracheal development.
In summary, neural ablation impedes branching morphogenesis in mammalian
lung and Drosophila trachea. In embryonic mouse lung, endothelial cell numbers
are reduced, and epithelial and mesenchymal proliferation are compromised. Acetyl-
choline receptor inhibition does not explain the defects in growth and branching,
suggesting that the nerves regulate branching morphogenesis independent of neu-
rotransmitter signaling. In the developmental condition congenital diaphragmatic
hernia, the diaphragm is malformed and lungs are reduced in size with sparse nerves
and thickened, constricted blood vessels (Pederiva et al., 2008, 2009). Understanding
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the role of nerves in regulating lung branching and subsequent innervation of known
targets such as vascular and bronchial smooth muscle may inform interventions to
supplement lung growth and vascular development in aected fetuses.
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Appendix A
PKC activation in the background
of SERCA inhibition fails to rescue
zebrash intersomitic vessel
outgrowth and branching
We tested whether reducing the release of calcium from the ER could balance the
inhibition of SERCA to pump calcium back into the ER and partially rescue inter-
somitic vessel growth and branching. The phorbol ester phorbol myristate acetate
(PMA) activates PKC and would thus be expected to reduce IP3-driven calcium
release (Castagna et al., 1982). Counting the number of intersomitic vessels that form
per embryo with DMSO (control), 5M CPA, 10nM PMA, or a combination of 5M
CPA and 10nM PMA shows no eect of co-incubating CPA with PMA (Fig. A.1A).
Approximately the same number of vessels form with PMA+CPA as with just CPA,
and PMA alone may cause a slight but insignicant reduction in the number of
vessels. With respect to the extent of branching of vessels 13-16 that form during
the middle of the incubation period, co-incubation with CPA and PMA results in the
same amount of branching as treatment with just CPA (Fig. A.1B). This remained
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true with varying degrees of SERCA inhibition and PKC activation.
Quantication of the height, length, and number of branches on individual vessels
that form at the end of the incubation period also demonstrated a lack of rescue of
intersomitic growth with PKC activation in the background of SERCA inhibition.
The measured values for branching (Fig. A.2A,D), length (Fig. A.2B,E), and height
(Fig. A.2C,F) were reduced approximately the same for SERCA inhibition alone
compared with PKC activation in addition to SERCA inhibition, and for the 19th
intersomitic vessel the dual treatment appeared to have an additive eect on vessel
length and height.
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Figure A.1: Activation of PKC in the background of SERCA inhibition fails to rescue
the number of intersomitic vessels that form or the extent of branching. (A) The
number of intersomitic vessels that form during the period of incubation following
just SERCA inhibition or SERCA inhibition plus PKC activation are approximately
the same. (B) The extent of branching of vessels that form during the middle of the
incubation period is the same for embryos treated with SERCA inhibitor alone or
PKC activator in addition to SERCA inhibitor. Median values for each treatment
group are indicated by red lines. Compared to controls, both vessel formation and
vessel branching are equivalently reduced by SERCA inhibition versus PKC activation
in the background of SERCA inhibition. Titrating the levels of SERCA inhibitor and
PKC activator gave the same result.
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Figure A.2: Caption next page.
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Figure A.2: Activation of PKC in the background of SERCA inhibition fails to rescue
the branching, length, and height of individual vessels that form near the end of
the incubation period. For the 19th and 20th intersomitic vessels, respectively, the
number of branches per sprout (A,D), vessel length (B,E), and vessel height from the
dorsal aorta (C,F) are similarly reduced following treatment with SERCA inhibitor
alone or PKC activator in addition to SERCA inhibitor. For the 19th vessel, the dual
treatment may even have an additive inhibitory eect on vessel outgrowth (B,C).
Median values for each treatment group are indicated by red lines. Titrating the
levels of SERCA inhibitor and PKC activator gave the same result.
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Appendix B
Additional examples of tracheal
and neural mutants with SERCA
inhibition and PKC activation
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Figure B.1: Additional examples of tracheal phenotypes observed following modu-
lation of SERCA activity. (A) Controls permeablized and treated with DMSO. (B)
Embryos treated with SERCA inhibitor. (C) Washout of SERCA inhibitor at stage
12. (D) Co-incubation with SERCA inhibitor and PKC activator. Throughout the
panels, yellow arrowheads point to breaks in the dorsal trunk, white arrowheads
indicate disruptions in smaller tubes, red arrowheads show hyper-sprouty and
elongated tubes, and pink arrowheads mark areas of faint lumen label in embryos
exposed to PKC activator. Anterior is up. Scale bar=50m throughout.
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Figure B.2: Additional examples of neural phenotypes observed following modulation
of SERCA activity. (A) Controls permeablized and treated with DMSO. (B) Embryos
treated with SERCA inhibitor. (C) Washout of SERCA inhibitor at stage 12. (D) Co-
incubation with SERCA inhibitor and PKC activator. Throughout the panels, yellow
arrowheads point to breaks or missing axons, white arrowheads indicate improper
spacing of longitudinal tracks, and red arrowheads mark aberrant fusing at the
midline. Anterior is up. Scale bar=50m throughout.
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